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Hisactophilin is a histidine rich, actin binding protein from Dictyostelium 
discoideum.  The structure of Hisactophilin, an all-beta protein, is typical of the beta-
trefoil superfamily of proteins.  In addition, hisactophilin is myristoylated, which is a 
relatively common co-translational modification involving the covalent attachment of a 
myristic acid group to the N-terminal glycine of a protein.  For most modified proteins, a 
myristoyl group is involved in reversible protein-protein and protein-membrane 
interactions via a myristoyl switch.  The majority of studies on the molecular basis of 
myristoyl switches have focused on characterizing calcium-myristoyl switches, whereas 
research has suggested that hisactophilin binds reversibly to membranes by means of a 
pH dependent myristoyl switch.  A number of in vivo studies of the modified protein have 
been completed to study the function of hisactophilin; however, the structure and stability 
of the protein have only been characterized using the recombinant non-myristoylated 
protein.  In contrast, this study focuses on the effects of myristoylation on hisactophilin 
structure and stability. Myristoylated hisactophilin has been prepared by a dual plasmid 
expression system in E. coli.  Optimization of the efficiency of myristoylaion was 
completed for the preparation and purification of myristoylated hisactophilin. 
Characterization of the structural changes caused by myristoylation were undertaken 
using multidimensional homo- and heteronuclear NMR experiments.  Circular dichroism 
(CD) was used to obtain low resolution structural data and characterize protein stability 
as a function of pH using chemical denaturation.  The molecular consequences of 
myristoylation on protein stability and structure, as well as the molecular basis for pH 
dependent myristoyl switch will be discussed. 
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CHAPTER 1 – INTRODUCTION 
 Co- and post-translational modifications of proteins occur relatively frequently 
and are often necessary for proper protein function.  These protein modifications may 
also play a role in the structure, stability and folding of a given protein.  For simplicity, 
most studies of protein stability and folding use recombinant proteins that are expressed 
in Escherichia coli.  E. coli is an excellent system for the production of highly pure 
protein; however, E. coli cells typically lack many enzymes responsible for protein 
modifications.  Thus some non-modified recombinant proteins may possess significantly 
different properties from those of the natural protein.  Little is known about the effects 
that protein modification has on the structure, stability and folding; a deeper 
understanding of this would be interesting for comparing the properties of recombinant 
proteins and the naturally modified proteins. 
 An example of a modified protein that has been extensively studied in its 
unmodified recombinant form is hisactophilin.  Hisactophilin is a histidine-rich, actin-
binding protein found in the model organism Dictyostelium discoideum.  Hisactophilin is 
modified by myristoylation, which is the attachment of a myristic acid group to the N-
terminus.  A number of in vivo studies of the modified protein have been completed to 
characterize its function (Schleicher et al., 1995; Scheel et al., 1989; Hanakam et al., 
1995; Hanakam et al., 1996); however, structure, stability and folding have been 
characterized using only the recombinant non-myristoylated protein (Habazettle et al., 
1992; Hammond et al., 1998; Liu et al., 2001; Liu et al., 2001).  The function of the 
myristoyl group of hisactophilin is not yet well defined.  For many proteins, the myristoyl 
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group is involved in reversible protein-protein and protein-membrane interactions, 
referred to as a myristoyl switch. 
 
1.1 – Protein N-myristoylation 
 Protein N-myristoylation is one of the most common lipid modifications of 
proteins (Resh, 1999). This modification occurs for eukaryotic (Resh, 1999) and viral 
proteins (Maurer-Stroh and Eisenhaber, 2004), but not for bacterial proteins.  N-
myristoylation consists of the co-translational attachment of a 14-carbon saturated fatty 
acid to the N-terminal glycine of a protein via an amide bond (Gordon et al., 1991) 
(Figure 1.1).   Although this common protein modification is necessary for many 
different cellular processes (Resh, 1996; Resh, 1999), myristic acid is considered to be a 
rare fatty acid (less than 2% of cellular fatty acids) (Gordon et al., 1991).  Myristic acid 
attachment to the protein is catalyzed by a well studied enzyme, N-myristoyl transferase 
(NMT).  The attachment process begins with the activation of myristic acid by FAA1 
acyl CoA synthetase to yield myristoyl CoA (Gordon et al., 1991).  A second necessary 
prerequisite step is the removal of the protein’s initiating methionine by methionine 
amino peptidase (MAP), to produce a protein with a free N-terminal glycine (Gordon et 
al., 1991).  The mechanism of myristoylation follows a Bi Bi reaction mechanism 
(Rudnick et al., 1991).  Initially, myristoyl CoA binds to NMT to yield the activated 
complex myristoyl CoA: protein N-myristoyl transferase.  This complex then binds 
selectively to the target protein (which is attached to the ribosome) and forms an amide 
bond between the myristic acid and the N-terminal glycine residue.  Next the CoA is 
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Figure 1.1 – Process of protein N-myristoylation 
Process begins with the activation of myristic acid with FAA1 acyl CoA synthetase to 
yield myristoyl CoA.  This activation is followed by binding of myristoyl CoA with 
NMT (Red circle).  Simultaneously, protein, which is in process of being translated, has 
its initiating Met cleaved by MAP.  Protein binds to NMT and the myristoyl group is 
covalently linked to the N-terminus via an amide bond.  This process is followed by 
release of CoA and finally NMT to yield myristoylated protein.  3
1.2 – N-myristoyltransferase 
Myristoylation occurs for many different eukaryotic and viral proteins and is 
considered to be vital in many cellular processes.  Because of this occurrence, NMT is 
considered an essential enzyme for many different species.  NMT has been found with 
many variations in amino acid sequence in a large number of organisms (Bhatnagar et al., 
1999).  Figure 1.2 is a phylogenetic tree outlining NMTs of various species and their 
relation through conserved residue sequences in their binding pocket.  The most widely 
studied NMTs are those from Saccharomyces cerevisiae (yeast NMT) (Bhatnagar et al., 
1999) and humans (Farazi et al., 2001).   
NMT is able to act upon a wide variety of different proteins within a given 
species (Maurer-Stroh et al., 2002).  Although N-terminal glycine is an absolute necessity 
for protein myristoylation, not all proteins with N-terminal glycine are myristoylated.  
These observations suggest the existence of a consensus motif for NMT protein 
substrates that extends upstream of the N-terminal glycine (Duronio et al., 1991).  Initial 
studies of S. cerevisiae demonstrated the importance of the first six residues (after 
methionine removal), which form an N-terminal consensus sequence of Gly-Xuncharged-
Xneutral-Xneutral-Ser/Thr-Lys (Utsumi, 2001).  This motif may be applicable for yeast NMT 
specificity, but with the presence of many differences in isozymes of NMT and species-
specific substrate specificity, a more general approach to defining the consensus motif is 
needed.  These differences in specificity are due to evolutionary differences in sequence 
at the NMT substrate binding pocket (N-terminus of NMT) found in different species and 






igure 1.2 – Phylogenetic tree of various NMTs 
ote the differences between D. discoideum, human (H. Sapiens) and yeast (S. 
erevisiae) NMT phylogeny, indicated by arrows (Maurer-Stroh et al., 2002). 5
 
Although NMT exhibits species-specific substrate specificity, extensive sequence 
comparisons of myristoylated proteins revealed additional conserved features (Maurer-
Stroh et al., 2002). These conserved features fall into two regions characterized by 
specific physical requirements.   These regions consist of the binding pocket region 
(residues 1-6) and the linker region (residues 7-17).  The residue requirements for 
myristoylation are described below and the primary structure of hisactophilin is given in 
Figure 1.3 for comparison. 
 
 
      M- 
1    G-N-R-A-F-K- 
7    S-H-H-G-H-F-L-S-A-E-G- 
18  EAVKTHHGHHDHHTHFHVENHGGKVALKTHCG 
50  KYLSIGDHKQVYLSHHLHGDHSLFHLEHHGGKVS 
85  IVSIKGHHHHYISADHHGHVSTKEHHDHDTTFEEIII 
 
Figure 1.3 – Primary sequence of the myristoylated protein hisactophilin 
The initial methionine is not included for residue numbering since it is cleaved during 
translation by MAP. Two regions of conserved features are highlighted.  Residues 1 to 6 
make up the binding pocket region and 7 to 17 make up the linker region (Maurer-Stroh 
et al., 2002). 
 
 
 The first NMT substrate recognition region is the binding pocket region which 
consists of residues 1 to 6 of the substrate protein.  These first 6 residues (again after 
methionine cleavage) need to fit deep within the NMT binding pocket to allow for 
myristoylation (Maurer-Stroh et al., 2002).  At position 1, glycine is required, without 
exception, for all myristoylated proteins.  Positions 2 and 3 require small residues to 
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allow fitting into the rather narrow binding pocket of NMT.  In addition, higher 
eukaryotic substrates require hydrophilic residues; whereas fungal substrates require 
hydrophobic residues.  Position 4 is preferentially occupied by large hydrophobic side 
chains (including tryptophan, phenylalanine and proline for higher eukaryotes); however, 
some species of fungi are unable to fit large residues and smaller residues are preferred in 
this position.  Position 5 is generally occupied by a small polar residue; however, a 
number of proteins with aspartic acid or phenylalanine (including hisactophilin) at 
position 5 are still found to be myristoylated. This position is found to be highly 
conserved among phyla and can vary for different species (this may be an important 
factor for high efficiency of myristoylation of hisactophilin discussed in Chapter 3).  
Finally, position 6 shows a preference for lysine or, less often, threonine.   
The second region of conserved residues is the linker region. The close interaction 
of the binding pocket region with NMT was originally thought to be the only constraint 
in substrate specificity; however, long range electrostatic interactions are, apparently, 
also important.  Residues 7 to 11 interact with the mouth of the binding pocket.  Residues 
7, 8 and 9 tend to have a flexible backbone and are hydrophilic; whereas, residues 10 and 
11 are relatively small and/or polar.  Residues 12-17 are the long-range linker region, and 
residues have a tendency to be polar residues. 
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1.3 – Myristoylated Proteins 
The proteins that undergo myristoylation have a variety of different functions and 
structural characteristics.  The function of myristoylated proteins most often involves 
signal transduction pathways or intracellular transport (Farazi et al., 2001).  The function 
of the myristoyl group is to aid in protein-membrane and protein-protein interactions 
(reviewed in Taniguchi, 1999).  The myristoyl group contributes in membrane binding by 
the simple means of the hydrophobic effect; however, the energy of this interaction alone 
is not sufficient for protein anchoring and other molecular interactions are also significant 
(McLaughlin and Aderem, 1995; Resh, 1999).  In most cases membrane binding is 
achieved by myristoylation along with electrostatic interactions of positively charged 
amino acids with negatively charged phospholipid head groups.  Neither the hydrophobic 
nor the electrostatic interactions alone have sufficient energy to anchor the protein to the 
membrane, and removal of one set of interactions will result in decreased binding.  This 
dual system of interaction for membrane binding is found in many different myristoylated 
proteins.  Figure 1.4 describes a number of different dual systems of interaction. 
The structural characteristics of myristoylated proteins have been studied for a 
variety of different proteins.  X-ray crystallography and stability studies have suggested 
that myristoylation may have significant effects on protein stability (Resh, 1999).  In 
addition, some protein structures possess a hydrophobic groove on the protein for binding 
the myristoyl group.  When bound in this groove the myristoyl group is unable to insert 
into the plasma membrane, which will result in decreased membrane binding for the 
protein.  In many cases the myristoyl group is able to move out of the hydrophobic 
groove and into an “on” position.  This scenario has been termed a “myristoyl switch” 
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and is common among myristoylated proteins.  Differences in switch triggers can be 
categorized as myristoyl-ligand, myristoyl-electrostatic or myristoyl-proteolytic switches 
(Figure 1.4) (Resh, 1999); these switches have been seen in some of the following 
examples.   
 
 
Figure 1.4 - Possible dual system models of membrane interactions. 
The myristoyl group alone is not sufficient for membrane anchoring, but, in the 
presence of electrostatic forces (basic), other acyl chains or other protein interactions 
membrane anchoring is possible. The spheres represent the myristoylated protein, and 




Figure 1.5 – Examples of different myristoyl switches. 
Myristoyl switches allow for the reversible binding of proteins to membranes. (A) 
Demonstrates the ligand-myristoyl switch in which binding of a ligand changes the 
conformation from “on” to “off” and facilitates membrane binding. (B) Is the myristoyl-
electrostatic switch. Here phosphorylation or other means (i.e. pH) changes the charge on 
the protein to cause dissociation.  (C) is the myristoyl-proteolytic switch where protein 
cleavage causes sequestering of the myristoyl group and dissociation (Resh, 1999). 
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1.3.1 – Cyclic AMP Dependent Protein Kinase 
 Cyclic AMP dependent protein kinase (cAPK) plays a crucial role in almost every 
eukaryotic organism by catalyzing the phosphorylation of regulatory proteins involved in 
cellular growth, metabolism and homeostasis (Gangal et al., 1999).  The myristoyl group 
of this protein is thought to lie within a large hydrophobic pocket formed by the N-
terminus and the catalytic domain (Figure 1.6) (Zheng et al., 1993).  It was initially 
proposed that the myristoyl group was present merely for increased structural stability 
(Yonemoto et al., 1993).  However, more recent information has revealed that the 
myristoylated catalytic subunit of the protein may be involved in some type of myristoyl-
electrostatic switch (Gangal et al., 1999; Tholey et al., 2001).  Information regarding the 
mechanism of the possible myristoyl-electrostatic switch of cAPK is limited, but 
myristoylation has been shown to have a crucial role in the overall structural stability of 
the protein.  
 
Figure 1.6 - Backbone 
structure of C subunit 
of cAPK.  
Note the location of 




stability (Gangal et al., 
1999).  
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1.3.2 – Calcineurin 
 Calcineurin (CaN) is a heterodimeric Ser/Thr protein phosphatase involved in 
many different biological roles such as ion channel regulation, gene transcription and 
neuronal depression (Kennedy et al., 1996).  The myristoyl group of this protein is 
situated in a hydrophobic groove situated between two alpha helices of the EF-hand 
structure of the protein (Rusnak and Mertz, 2000).  Membrane binding capabilities of the 
protein that are independent of myristoylation have been determined, and evidence of a 
myristoyl switch has yet to be found (Rusnak and Mertz, 2000; Kennedy et al., 1997).   
The physiological role of the myristoyl group may not be known, but the myristoylation 
is known to significantly increase thermal stability of the protein (Kennedy et al., 1996). 
 
1.3.3 – Recoverin 
 Recoverin is a calcium binding protein which blocks phosphorylation of 
rhodopsin to prolong the photoresponse (reviewed in Ames et al., 1996).  Recoverin is a 
member of the EF-hand superfamily of proteins and is myristoylated (Ames et al., 1996; 
Dizhoor et al., 1992).  This protein has been characterized in detail with respect to its 
membrane binding ability via a calcium-myristoyl switch (Zozulya and Stryer, 1992; 
Ames et al., 1997) (Figure 1.7).  For recoverin, in the calcium-free state the myristoyl 
group is sequestered within a relatively deep hydrophobic pocket between helices 
(Tanaka et al., 1995) (Figure 1.8).  The myristoyl group is “clamped” in this pocket by an 
N-terminal helix; this helix is unstructured in the non-myristoylated form of the protein 
and some studies suggest that the myristoyl group stabilizes the formation of this helix 
(Ames et al., 1994b).  Through NMR experiments the structure and the location of the 
myristoyl group change markedly upon cooperative calcium binding (Ames et al., 1994b; 
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Senin et al., 2003).  The myristoyl group extrudes from the protein, becoming solvent 
accessible and is then able to interact and bind to membranes (Figure 1.7) (Ames et al., 
1995).  The structures of both the calcium-free and calcium-bound states have been 
determined by NMR and are shown in Figure 1.8 (Ames et al., 1997).  The binding of 
recoverin to the membrane occurs through insertion of the myristoyl group into the 
membrane along with other electrostatic forces; this process has little effect on the 
protein structure (Valentine et al., 2003).  
Figure 1.7 – Schematic diagram of the Ca2+-myristoyl switch 
The binding of two or Ca2+ ions induces a conformational change exposing the 




Figure 1.8 – Ribbon diagram of Ca2+-free and Ca2+-bound myristoylated recoverin 
Ca2+-free is found on the right and Ca2+-bound is on the left. The myristoyl group is 
coloured pink and Ca2+ is gold (Ames et al., 1997)  
 
1.3.4 – Frequenin and Other Neuronal Calcium Sensors 
 Frequenin and other neuronal calcium sensors are calcium-binding proteins which 
regulate many different cellular functions such as neurotransmitter release, potassium 
channels and voltage-gated calcium channels of both excitable and non-excitable cells 
(O’Callaghan et al., 2002).  These proteins are closely related to recoverin in that they 
both are calcium binding proteins of the EF-hand superfamily and are myristoylated 
(Burgoyne, 2004).  Denaturation experiments using guanidine HCl (GdnHCl) have 
shown that myristoylation of neuronal calcium sensors increase the structural stability of 
the protein (Muralidhar, 2005). This protein has been found to bind to membranes in a 
myristoyl and calcium dependent manner similar to that of recoverin (O’Callaghan et al., 
2002; Ladant, 1995; Ames et al., 2000).  However, research has determined that the 
NMR and fluorescence spectrum are nearly identical upon calcium binding (Ames et al., 
2000).  These findings suggest that the myristoyl group is not confined to a hydrophobic 
pocket of the protein in the absence of calcium as in recoverin.  
 
1.3.5 – ADP-ribosylation Factors 
 ADP-ribosylation factors (Arfs) are the protein cofactor for cholera toxin-
catalyzed ADP ribosylation and also serve a regulatory role in protein secretion and 
membrane trafficking by interaction with the Golgi apparatus (Kahn et al., 1992).   Arf is 
a myristoylated alpha/beta protein that is made up of a β-sheet core surrounded by α-
helices (Amor et al., 1994).  Arfs undergo a myristoyl-GTP switch to regulate membrane 
binding (Randazzo et al., 1995).  The structure of the non-myristoylated protein suggests 
that there is a hydrophobic groove between two β-strands to accommodate the myristoyl 
group in its “off” state (Amor et al., 1994).  Upon activation of the protein by GTP 
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binding, Arfs have increased membrane binding affinity (Randazzo et al., 1995).  The 
myristoyl group itself is not sufficient for membrane binding (Haun et al., 1992); 
however, the presence of the myristoyl group increases protein helical content and 
produces a new hydrophobic face for increased membrane binding (Harroun et al., 2005).  
The actual molecular details of the switch have not yet been elucidated but extensive 
evidence suggests that Arfs undergo a myristoyl-GTP switch.   
 To summarize, myristoyl switches are found in many different proteins that have 
diverse functions.  In general, very little data on the molecular details and basis for the 
switches has been collected.  Hisactophilin provides and interesting opportunity to 
understand molecular characteristics of the myristoyl switch. 
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1.4 – Hisactophilin 
 
1.4.1 – Chemical Properties and Function of Hisactophilin 
Hisactophilin is an actin binding protein found in the highly motile amoeboid 
cells of the slime mold Dictyostelium discoideum (Schleicher et al., 1995).  D. 
discoideum is a model organism that has been used extensively to study cytoskeletal 
structure and dynamics.  Remarkably, the sophisticated mechanism of cytoskeletal 
rearrangement that allows for the organism’s high motility is extremely similar to those 
of higher organisms (reviewed in Schleicher et al., 1995).  Actin binding proteins, such as 
hisactophilin, act by polymerizing or depolymerizing actin filaments or by cross-linking 
actin filaments to each other or to membranes (Schleicher et al., 1995).  In the case of 
hisactophilin, the protein binds to actin in a pH dependent manner (Scheel et al., 1989).   
Hisactophilin is a histidine-rich protein found to exist free in the cytoplasm as 
well as being membrane bound (Scheel et al., 1989).  Also, this protein exists in two 
isoforms (denoted as HisI (13.5kDa) and HisII (13.7kDa)), both of which are 
myristoylated and very similar in sequence and function (Hanakam et al., 1995).  The 
difference in the two isoforms involves a small variation in amino acid sequence; 
however, the N-terminal myristoylation consensus motifs for the two isoforms are 
identical (Hanakam et al., 1995).  Both isoforms consist of 118 amino acids, of which 31 
are histidine for HisI and 36 for HisII.  This high histidine content gives the isomers 
isoelectric points of 6.9 for HisI and 7.1 for HisII.  Also, the two isoforms can form 
hetero- and homodimers.  Lastly, the isomers are substrates of a membrane associated 
threonine/serine kinase; phosphorylation of hisactophilin has been proposed to have some 
regulatory role in its membrane interaction or in actin binding (Hanakam et al., 1995). 
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The covalently bound myristoyl group is crucial for the binding of hisactophilin to 
membranes (Behrisch et al., 1995).  This binding is thought to function by way of a 
myristoyl-histidine switch (Hanakam et al., 1996a), which is modulated by cytoplasmic 
pH levels or possibly by phosphorylation (Hanakam et al., 1996b).  In vivo studies have 
shown that membrane binding increases upon a decrease in cytoplasmic pH (Hanakam et 
al., 1995).  Other evidence for a pH dependent myristoyl-histidine switch for membrane 
binding is also based upon structural evidence determined by NMR (Habazettle et al., 
1992a; Hanakam et al., 1995).  Figure 1.9 shows a model for membrane binding and 





Figure 1.9 - Model of hisactophilin insertion into the inner lipid layer of the plasma 
membrane.  Histidine residues (coloured dark) are thought to be involved in pH dependent 
actin binding.  Model of F-actin shows relative sizes - indicating a possible location for 
hisactophilin binding (Hanakam et al., 1995).
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1.4.2 – Structure of Non-myristoylated Hisactophilin 
 The three-dimensional structure of non-myristoylated hisactophilin has been 
solved by NMR spectroscopy (Habazettl et al., 1992a).  The structure of hisactophilin is 
unlike any of the examples described earlier, since it is an all beta protein whereas the 
others were mostly alpha helical proteins with some amount of beta structure present.  
Hisactophilin is a member of the beta trefoil superfold which consists of the cytokines 
(including interleukin-1β (IL-1β)), basic and acidic fibroblast growth factors (FGF), ricin 
B-like, agglutinin, kunitz inhibitors and hisactophilin (Figure 1.10) (Murzin et al., 1995).  
These proteins have less than 10% sequence homology, but nevertheless retain the same 
overall fold (Murzin et al., 1992).  There are, however, residues within the proteins that 
are conserved to allow for the high similarity in folds (Xu and Xiao, 2005; Murzin et al., 
1992).  These minor sequence similarities have led Ponting and Russel (2000) to the 
conclusion that β-trefoil proteins may have descended from a common protein ancestor. 
 




The structure of the β-trefoil fold in hisactophilin consists of twelve β-strands 
organized into three similar four-stranded trefoil units, as illustrated in Figure 1.11.  Each 
of the trefoil units consists of a β-β-β-loop-β motif where the first and fourth β-strands 
form an anti-parallel β-sheet. Three of these β-sheets (one from each trefoil unit) make up 
a β-barrel and the remaining β-strands cover one end of the β-barrel in a triangular 
hairpin triplet (Figure 1.11).  Of the many histidine residues, 90% reside on the surface of 
the protein in loops and turns, and are highly exposed to solvent (Figure 1.12).  The 
histidines generally have pKa values of 6.8 (Hammond et al., 1998), consistent with the 
pH dependence of the proposed myristoyl-histidine switch.  That is, a slight decrease in 
intracellular pH would cause large portions of the protein surface to become positively 
charged by protonation of the histidines and allow for favourable interactions with 
negatively charged membranes and actin.   
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Figure 1.11 – Two-dimensional representation of the tertiary structure of hisactophilin.  
Each residue is depicted by a circle with the corresponding residue number inside.  
Colour coding represents the different pKa values for each amino acid. Hydrogen 
bonds between residues are shown by dotted lines.  From this figure the β-trefoil 
structure is clearly evident.  The six β-strands in the centre make up the β-barrel and 































































The structural aspects of this study were based upon the structure of the non-
myristoylated form of the protein; it was assumed that the structure of myristoylated 
hisactophilin will be similar.  Circular Dischroism (CD) spectroscopy data have been 
collected for both isoforms of hisactophilin and compared to the CD spectrum of the non-
myristoylated protein (Figure 1.13).  CD spectra were nearly identical, suggesting that 
myristoylation has little effect on the secondary structure of the protein (Hanakam et al., 
1996b).  This is similar to data obtained for other proteins, described above, that also 
showed structure was not greatly affected by myristoylation.  
Figure 1.13 – CD spectra of myristoylated and non-myristoylated hisactophilin 
Solid lines represent 50/50 (mole/mole) myristoylated HisI/HisII at (1) pH 8; (2) pH 
6; (3) pH 3.  Dotted line (4) represents the spectrum of non-myristoylated 
hisactophilin.  Spectra are nearly identical (Hanakam, 1996).  
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1.4.3 – Stability and Folding Studies of non-Myristoylated Hisactophilin 
 The stability and folding of non-myristoylated hisactophilin has been 
characterized in detail previously in our group.  It was determined that the unfolding of 
non-myristoylated hisactophilin is greater than 90% reversible for urea induced 
unfolding, and at least 80% reversible for thermal denaturation (Liu et al., 2001).  The 
denaturation data can be well fit using a two-state transition model.  From these 
denaturation studies, hisactophilin was found to have moderate and fairly constant 
stability from pH 7.7 to 9.7; however, below pH 7.7 stability decreases dramatically due 




















Figure 1.14 – Fluorescence-monitored denaturation curves of hisactophilin. 
Curves are measured for pH 5.7 (●), pH 6.7 (■), pH 7.7 ( ), pH 8.7 (▲) and pH 9.7 
(♦), displayed in terms of the fraction of unfolded protein. Hisactophilin stability 
increases markedly from pH 5.7 to 7.7, and then remains relatively constant from pH 




The folding kinetics of non-myristoylated hisactophilin have also been studied 
using optical probes as well as quenched flow hydrogen-deuterium exchange methods.  
The slowly exchanging amides of hisactophilin tend to be similar to those found in IL-1β, 
another β-trefoil protein, and may be conserved among this superfold (Houliston, 2002).  
In most cases of β-trefoil proteins, the folding is relatively slow and occurs via formation 
of intermediates.  In the case of hisactophilin, the folding is much faster and apparently 
follows a two-state model, except under the most stabilizing solution conditions (Liu et 
al., 2002).  In this case, the folding intermediate for hisactophilin was found to resemble 
the IL-1β intermediate, but differs from that of FGF (Liu et al., 2002).  These differences 
are thought to be due to the differences in non-conserved loops that are involved in 
protein function. 
 
1.5 – Experimental Objectives  
 The majority of studies on the molecular basis of myristoyl switches have been 
concerned with characterizing calcium-myristoyl switches whereas, as discussed above, 
hisactophilin is thought to bind reversibly to membranes by means of a pH dependent 
myristoyl switch.  A number of in vivo studies on the modified protein have been 
completed to study the function of hisactophilin; however, the structure and stability of 
the protein have only been characterized using the recombinant non-myristoylated 
protein.  This study focuses on the effects of myristoylation on hisactophilin structure and 
stability. To achieve this, a co-expression system was used to produce recombinant 
myristoylated hisactophilin in E. coli.  Unfortunately, despite a number of optimization 
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experiments, this expression system yielded only 85% myristic acid incorporation and, 
which required a new purification protocol to separate myristoylated and non-
myristoylated protein.  Initial characterization of the structural changes caused by 
myristoylation has been undertaken using homonuclear and heteronuclear NMR.  In 
addition, preliminary studies on the stabilizing effects of myristoylation were obtained by 
urea denaturation. The molecular consequences of myristoylation on protein stability and 




CHAPTER 2 – PREPARATION OF RECOMBINANT MYRISTOYLATED 
HISACTOPHILIN BY A DUAL PLASMID EXPRESSION SYSTEM IN E. COLI 
 
 
2.1 – Introduction 
 
The hisactophilin gene (cDH516) was initially sub-cloned into the plasmid pIMS5 
and is designated pHisI (Simon et al., 1988); however, this plasmid contains 4 additional 
amino acids at the N-terminus of the protein (Habazettl et al., 1992a).  These additional 
amino acids will cause a significant decrease in NMT activity due to N-terminal 
specificity of NMT.  The inserted amino acid codons were deleted from the original 
plasmid by site-directed mutagenesis, yielding a plasmid designated pHW (Wong, 2002) 
(For plasmid map refer to Figure 2.1).  pHW contains an IPTG-inducible Ptac promoter, 
b-lactamase for ampicillin resistance and the pBR322 origin of replication (Scheel et al., 
1989; Wong, 2002).    
 For this project, three plsamids encoding different isoforms of NMT were 
available for testing their ability to myristoylate hisactophilin (Figure 2.1).  The first 
NMT plasmid, pBB131, encodes the Saccharomyces cerevisiae NMT1 or yeast NMT1 
(yNMT) for expression in E. coli (Duronio et al., 1990).  Another NMT plasmid that is 
available for the myristoylation of hisactophilin encodes for human NMT.  There are, 
however, two genetically distinct human NMTs which are denoted as hNMT1 and 
hNMT2 (Giang and Cravatt, 1998).  Genes for hNMT1 and hNMT2 have been sub-
cloned onto plasmids and were designated pHV641 and pHV644 respectively (Van 
Valkenburgh and Kahn, 2002).  Along with cloning the human NMT genes, Van 
Valkenburgh and Kahn (2002) attempted to increase levels of myristoylation by 
increasing the expression of bacterial methionine aminopeptidase (MAP).  Since the N-
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terminal methionine of the protein must be cleaved prior to myristoylation, an insufficient 
level of MAP could lead to a decrease in protein myristoylation.  To remedy this, the 
hNMT plasmids were modified by the insertion of the bacterial MAP gene (Van 
Valkenburgh and Kahn, 2002).  These plasmids are denoted as pHV738 (hNMT1+MAP) 
and pHV739 (hNMT2+MAP).  All of the NMT plasmids discussed are based upon the 
same parent plasmid and therefore have similar expression properties.  That is all the 
NMT plasmids contain the p15A origin of replication and possess kanamycin resistance.  
Also, the NMT plasmids contain the IPTG inducible Ptac promoter for NMT expression; 
in the case of pHV738 and pHV739 MAP expression is endogenous (Duronio et al., 
1990; Van Valkenburgh and Kahn, 2002).  The NMT plasmids and hisactophilin plasmid 
(pHV and pHW, Figure 2.1) have different but compatible origins of replication.   
 
Figure 2.1 – Plasmids used for preparing myristoylated hisactophilin. 
Restriction sites for pBB131 (encoding yeast NMT), pHW (encoding hisactophilin), 
human NMT1 (pHV641), human NMT1+MAP (pHV738), human NMT2 (pHV644) and 
human NMT2+MAP (pHV739). Coding sequences for various genes are shown by thick 
lines (Wong, 2002) 
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E. coli does not have endogenous NMT activity; therefore, to achieve 
myristoylation of a recombinant protein, a co-expression system is required (Duriono et 
al., 1990).  These two plasmids encode or confer different antibiotic resistances 
(ampicillin for pHW and kanamycin for NMT), but use the same IPTG inducible Ptac 
promoter for expression.  To allow for myristoylation, a co-expression system was 
created and the success of myristoylation was monitored by a slight modification to the 
protocol outlined by Knoll et al. (1995), which is described below. 
 The co-expression system for myristoylation was accomplished with E. coli cells, 
which were transformed with a plasmid encoding NMT and pHW by electroporation.  
Electroporation is a highly efficient (nearly 80%) means of transforming plasmid DNA 
into bacterial cells, as noted in the protocol outlined by Miller and Nikoloff (1995). 
Electroporation involves a structural rearrangement of the cell membrane caused by the 
application of a short electric field pulse.  This electric field causes pore formation and 
the driving force to transport plasmids into the cell (Weaver, 1995).  Upon 
transformation, simultaneous resistance to ampicillin (pHW plasmid) and kanamycin 
(NMT plasmid) was selected by plating transformed cells on media containing ampicilin 
and kanamycin (Sambrook et al., 1989).  The plasmids of the transformed cells were 
induced and myristic acid incorporation was monitored using radioactive [3H]myristic 
acid.  Myristic acid penetrates across the plasma membrane by simple diffusion (Knoll 
and Gordon, 1993) and is then activated by the acyl-CoA synthetase fadD located on the 
inner membrane of the bacterial cell (Duronio et al., 1990).  Cells were harvested by 
centrifugation and whole cell lysate was analyzed by SDS-PAGE and fluorography for 
the presence of myristoylated hisactophilin. 
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Fluorography was employed to visualize the radioactively labeled [3H]myristic 
acid to ensure its covalent attachment to hisactophilin.  Fluorography was used rather 
than simple autoradiography due to the low energy of tritium β-particles.  
Autoradiography is the direct exposure of the radioactive material to an x-ray film.  This 
method of developing radioactively labeled gels is relatively straightforward; however, in 
this case, the energy of the emitted β particles is so low that they do not have sufficient 
energy to penetrate the acrylamide gel and contact the x-ray film.  To remedy this 
problem associated with autoradiography, fluorography is used for most low energy β-
emitters (Strahler et al., 1989).  Fluorography allowed for sufficient exposure under more 
tractable time frames.  Fluorography involves the addition of a scintillant to the 
acrylamide gel which will absorb the energy of the radiation and re-releases the energy as 
fluorescent light (Strahler et al., 1989).  This fluorescent light then can be easily 
visualized on x-ray film.  In most cases, the scintillant 2,5-diphenyloxazole (PPO) is used 
and is introduced to the gel by way of dimethylsulfoxide (DMSO); however, for this 
work, a commercial fluorographic cocktail was used to simplify the process.   
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2.2 – Materials and Methods 
 
2.2.1 – Plasmid Preparation 
All plasmids were prepared by using a FlexiPrepTM Kit from GE Healthcare Life 
Sciences (Piscataway, NJ) according to the manufacturer’s directions.  Plasmids coding 
for hisactophilin (pHW1 and pHW3) were obtained from Hannah Wong.  The pBB131 
plasmid was obtained from Dr. Jeffery Gordon (Washington University School of 
Medicine).  The plasmids encoding for hNMT along with those encoding Arf were 
graciously donated by Dr. Richard Kahn (Emory University, School of Medicine).   
 
2.2.2 – Media preparation 
LB media was prepared by dissolving 20g of LB (BioShop Canada Inc., 
Burlington, ON) in 1L of distilled deionized water (ddH2O) and autoclaving.  LB-agar 
plates were prepared by adding 15g of agar (BioShop Canada Inc.) to 1L of LB media 
and autoclaved to dissolve the agar.  The LB-agar was then cooled to 50oC using a water 
bath prior to adding ampicilin (100µg/mL) and kanamycin (30µg/mL).  After adding 
antibiotics, approximately 30mL was poured into sterile plastic Petri dishes and allowed 
to set.  Plates were stored at 4oC; prior to use plates would be equilibrated at 37oC.  
 
2.2.3 – Preparation of Electrocompetent Cells and Transformation 
Cell stocks (TG2 and BL21(DE3)) were made competent by inoculating 10mL of 
LB media and incubated at 37oC with 200 rpm of shaking overnight.  5mL of this 
overnight culture was then used to inoculate 500mL of LB media which was allowed to 
grow to mid-log phase with an A600 of 0.7 at 37oC with shaking at 200 rpm.  Once cells 
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had reached mid log phase, they were placed on ice for approximately 20 minutes.  Cells 
were harvested by centrifugation at 4000g for 15 minutes and at 4oC.  The supernatant 
was removed and the cells were washed by resuspending in 500mL of ice cold sterile 
10% glycerol (EMD Pharmaceuticals, Durham, NC).  The cells were collected again by 
centrifugation and the wash was repeated with 250mL and 20mL of the glycerol.  The 
competent cells were resuspended in a final volume of 2mL of 10% glycerol, flash frozen 
in liquid nitrogen as 80uL aliquots and stored at -80oC. 
Plasmids coding for a target protein and hNMT2 were co-transformed into 
competent E. coli cells (strain TG2 for Hisactophilin and BL21(DE3) for hArf) by 
electroporation.  The electroporation was performed with 40µL of competent E. coli cells 
mixed with 1µL of prepared plasmid which coded for the protein and 1µL of prepared 
plasmid which coded for hNMT2.  This mixture was incubated on ice for 1 minute and 
transferred to a sterile electroporation cuvette with 0.1 cm electrode gap (Bio-Rad 
Laboratories, Hercules, CA) .  The electroporation was performed using a Bio-Rad Gene 
Pulser (Bio-Rad Laboratories) and operated according to the manufacturers directions for 
the electroporation of E. coli.  Immediately after electroporation, the transformed cells 
were added to 1mL of SOC (2% bacto-tryptone, 0.5% bacto-yeast extract, 10mM NaCl, 
1.5mM KCl, 10mM Mg2Cl, 10mM MgSO4, 20mM glucose) and incubated at 37oC with 
200 rpm shaking for 1 hour to allow the cells to build antibiotic resistance.  The 
transformed cells were then plated on agar plates containing 100µg/mL ampicillin 
(BioShop Canada Inc.) and 30µg/mL kanamycin (BioShop Canada Inc.) and incubated at 
37oC, overnight.   
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2.2.4 – Preparation of Radioactively Labeled [3H]-Myristoylated Protein 
Single colonies were isolated and used to inoculate 10mL LB cultures (containing 
100µg/mL ampicillin and 30µg/mL kanamycin) incubated at 37oC and 200 rpm shaking 
overnight.  150µL of the overnight culture was used to inoculate 15mL LB cultures 
(containing ampicillin and kanamycin) which were allowed to grow to A600 of 0.7 at 37oC 
with shaking at 200 rpm.  Once the cells reached an A600 of 0.7, both plasmids (coding 
for protein and NMT) were induced, simultaneously, with a final concentration of 1mM 
IPTG (BioShop Canada Inc.).  Immediately, a 2mL aliquot of the induce cells was 
distributed to 200µCi of [3H]myristic acid (Perkin Elmer Life Sciences, Inc., Boston, 
MA) which was prepared in a sterile 15mL falcon tube.  [3H]Myristic acid was prepared 
by drying 200µL of the stock solution (0.100µCi/mL [3H]myristic acid) under nitrogen 
(which was filtered through a 0.2µm filter).  The 2mL radioactive cultures were allowed 
to grow for 1.5 hours at 37oC with 200rpm shaking.  The cells were then harvested by 
centrifugation (4000g for 10 minutes) and the supernatant was removed by aspiration.  
The pellets were stored at -20oC 
. 
2.2.5 – SDS-PAGE and Fluorography 
Pellets were resuspended in 100µL of 1x SDS-PAGE loading buffer (125mM Tris 
pH 6.8, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol).  Samples were boiled for 10 
minutes and gently centrifuged to collect water droplets.  4.5µL of each sample were 
loaded onto a 0.75mm thick, 10cm, self cast, 15% SDS-PAGE gel and run with a 
constant current of 8mA until the dye front reached the end of the gel (~3 hours). SDS-
PAGE was performed using a Mighty Small II Gel Electrophoresis Unit (Pharmacia 
 34
Biotech Inc. San Francisco, CA). The gel was stained with coomassie brilliant blue R-250 
(Sigma Chemical Company, St. Louis, MO).   
Fluorography was performed by following the protocol set forth by Strahler et al. 
(1989).  After the gel had been destained it was rinsed with ultra pure water filtered with 
a milliQ water system (Millipore Ltd., Bedford, MA) and treated with the commercial 
fluorographic cocktail, AmplifyTM Fluorographic Reagent (Amersham Biosciences, 
Piscataway, NJ) for 30 minutes at room temperature and gentle agitation.  The Amplify 
was decanted; the gel was rinsed with water and dried on Whatman No. 1 filter paper 
(VWR, Mississauga, ON) in a Bio-Rad model 443 slab dryer (Bio-Rad Laboratories) for 
1.5 hours at 60oC.  The x-ray film, HyperfilmTM MP high performance autoradiography 
film (Amersham Biosciences) was cut to the same size as the gel (in complete darkness) 
and pre-flashed using an orange O2 filtered (Pentax Imaging Company, Westminster, 
CO) flash.  In order for the film to have an absorbance at 540nm wavelength between 
0.10 and 0.2 (after development) the flash was placed 90cm from the film and covered 
with 1 piece of Whatman No. 1 filter paper (VWR).  After pre-flashing, the film was 
positioned against the gel and taped into an autoradiography cassette; the cassette was 
then placed into a lightproof bag stored at -80oC for the duration of the exposure. After a 
10 day exposure, the X-ray film was warmed to room temperature prior to development.  
Under the safety light the film was immersed for 2 minutes with constant shaking in the 
Kodak GBX developer solution (Amersham Biosciences).  This was followed by an 
approximately 15 second rinse with water and 4 minutes in the Kodak GBX fixer solution 
(Amersham Biosciences) with intermittent shaking.  The film was then rinsed for at least 
15 minutes and hung to dry. 
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2.3 – Results and Discussion  
 
 
2.3.1 – Plasmid Expression in E. coli 
 
All plasmids used for co-expression were checked for expression of the desired 
proteins in both TG2 and BL21(DE3) cell lines.  Each plasmid was transformed into E. 
coli, induced with IPTG and whole cell lysate was analyzed by SDS-PAGE before and 
after induction.  For each plasmid, bands increased in intensity after induction were seen 
and have expected molecular weight. 
Figure 2.2 shows that the hisactophilin band runs slower than one would expect 
based on its known molecular weight of 13.5kDa.  This is most likely due to the high 
number of histidine residues that are present in this protein.  In addition, the pHW1 
plasmid seems to have a rather leaky expression, as a fairly intense hisactophilin band is 
apparent prior to induction.  It is difficult to ascertain if the NMT proteins also have leaky 
expression as the NMT band is in a crowded region of the gel.  This may be problematic 
for achieving high yields of myristoylated protein since hisactophilin will be produced in 
the absence of the NMT protein and therefore myristoylation will not occur.  In addition, 
as we discuss in the following chapter, myristic acid is not added to the initial media, so 
even if the NMT protein has a similar leaky expression (which may be expected for 
plasmids with similar promoters) the excess myristic acid will not be available for 




























Figure 2.2: SDS PAGE of proteins for co-
expression system.  Lane 1 was loaded 
with a molecular weight marker. Lanes 2-
5 were loaded with whole cell lysate
transformed with a single plasmid: (A) 
pHW1 (hisactophilin), (B) pJCY1-74 
(lanes 2 and 3 with yArf1) and pJCY1-75 
(lanes 4 and 5 with y[G2A]Arf1) and (C) 
pHV739 (hNMT2). Pre-induction cells 
were grown to an A600 of 0.7; harvested 
cells were induced with 1M IPTG and 








































2.3.2 – Verification of Co-Expression System by Radioactive Labeling 
To produce myristoylated hisactophilin through a recombinant system in E. coli, a 
dual expression system of plasmids pHW1 (hisactophilin) and pHV739 (hNMT2 and 
MAP) was prepared in TG2 cells.  The plasmid pHV739 was chosen for two reasons.  
Firstly, previous studies have shown that yNMT1 either does not myristoylate 
hisactophilin or does so at very low levels that were not detected by the methods that 
were employed previously to monitor incorporation (Wong, 2000).  In addition the 
yNMT1 has the lowest sequence homology to hisactophilin’s cognate NMT (the D. 
discoideum NMT). On the other hand, hNMT2 has the highest sequence homology to the 
D. discoideum NMT.  In addition to coding for hNMT2, the pHV739 plasmid also codes 
for bacterial MAP.  The additional MAP that will be produced from the plasmid should 
ensure that all N-terminal methionine is cleaved from the hisactophilin and allow for 
maximum levels of myristoylation.   
To determine whether hisactophilin was properly myristoylated by the co-
expression system, a number of controls were implemented.  The first negative control 
consisted of the preparation of an E. coli TG2 cell line that carried only the pHW1 
plasmid and a cell line that carried only the hNMT2 plasmid.  For a positive control, the 
co-expression system was tested using the pHV739 (hNMT2) plasmid with a plasmid of 
a known NMT substrate.  In this case, the plasmids used encode for yeast Arf1 which is 
designated as pJCY1-74; this system has already been successful in other studies 
(Duronio et al., 1990; Van Valkenburgh and Kahn, 2002).  In addition to this plasmid 
which expresses Arf1, another negative control was applied using an NMT plasmid co-
expressed with a plasmid designated pJCY1-75, which expresses a gly2-ala mutation of 
the yeast Arf1 (yeast [G2A]Arf1) protein.  This mutation does not allow for 
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myristoylation because of the absence of N-terminal glycine.  Like pHW, these plasmids 
confer ampicillin resistance; however, they have the ColE1 origin of replication and 
utilize the T7 promoter.  Due to the T7 promoter of these plasmids, E. coli BL21(DE3) 
cells were needed to allow for expression.   
 Figure 2.3 shows that hisactophilin can be myristoylated using the co-transformed 
E. coli system.  The control experiments (lanes 1, 4 and 6) show no incorporation of the 
radioactively labeled [3H]myristic acid into the target proteins, while there is obvious 
incorporation of myristic acid with the yArf1 (lane 5) and hisactophilin (lane 2) seen in 
the fluorograph (figure 2.2 B). In addition, the fluorograph also shows high intensity 
signals for all lanes in the lower portion, which correspond to unused [3H]myristoyl-CoA 
present in the whole cell lysate.  Also, there are some low levels of myristoylation for 
other proteins indigenous to E. coli and happen to fit the somewhat loose consensus motif 
of hNMT2. 
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Figure 2.3: Visualization of myristoylation using a radioactively labeled 3H myristic 
acid assay.  (A) 15% SDS PAGE of myristoylated proteins; controls and (B) 
resulting x-ray film from fluorography.  Lanes were loaded with whole cell lysate of 
cells transformed with the following plasmids: (1) pHW (hisactophilin only control), 
(2) pHW and pHV739 (myristoylated hisactophilin), (3) molecular weight marker, 
(4) pJCY1-75 and pHV739 (y[G2A]Arf1 negative control), (5) pJCY1-74 and 
pHV739 (myristoylated yArf1) and (6) pHV739 (hNMT2 only).  Arrows indicate 3H 
myristic acid incorporation for hisactophilin, Arf1 and a weak band corresponding to 
the migration of hNMT2.  The large bands at the bottom of the fluorgram represent 
unincorporated 3H-myrsitoyl CoA. 
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2.4 – Summary 
 
 The radioactively labeled [3H]myristic acid test preparations clearly demonstrate 
that hisactophilin can be myristoylated using a dual plasmid system in E. coli.  E. coli 
TG2 cells transformed with pHW1 (hisactophilin) and pHV739 (hNMT2 with MAP) 
allows for significant myristoylation of hisactophilin.  In order to perform structural 
studies of the protein the preparation was scaled up for large scale purified of 
myristoylated hisactophilin, described in the following chapter. 
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CHAPTER 3 – OPTIMIZATION OF SCALED-UP PREPARATION AND 
PURIFICATION OF MYRISTOYLATED HISACTOPHILIN 
 
 
3.1 – Introduction 
 
In most cases, myristoylated proteins are purified in the same manner as their 
non-myristoylated forms because the two forms of the protein behave in a similar manner 
(Knoll et al., 1995); however, in some cases, such as for hisactophilin, additional 
purification steps are required to separate unmodified protein (Fisher et al., 2000; Haun et 
al., 1992).  Therefore, myristoylated hisactophilin has been purified previously in the 
same manner as non-myristoylated hisactophilin, with an additional purification step 
required to separate myristoylated and non-myristoylated forms of the protein.  The 
purification protocol is a slight modification of that previously described by Scheel et al. 
(1989).   
Myristoylated protein can be purified from a natural system or through an over 
expression system in E. coli (as outlined in section 1.1).  An over expression system will 
result in higher protein yields compared to a natural system; however, the production of 
myristoylated protein in E. coli requires a dual expression system (i.e. one plasmid for 
target protein expression and one for NMT expression), because E. coli does not have 
endogenous NMT activity, which often results in a low efficiency of myristoylation.  
This has been found for some proteins such as Goα, recoverin and Arf proteins (Knoll et 
al., 1995, Ray et al., 1992 and Khan et al., 1992, Yonemoto et al., 1993); this was also 
found to be also true for the myristoylation of hisactophilin.  Low levels of 
myristoylation have been speculated to be caused mainly by low solubility of the myristic 
acid in the bacterial cell environment (Van Valkenburgh and Kahn, 2002).  In some 
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cases, to correct for poor solubility it may be necessary to substitute myristic acid with 
shorter acyl chains or myristic acid analogs (Van Valkenburgh and Kahn, 2002).  A 
solution to the problem of low levels of myristoylation has been found through 
modification of induction times, inducer concentrations and growth temperatures.  First, 
induction times and inducer concentration may need to be manipulated to find a good 
balance for optimal myristoylated protein (Randazzo and Kahn, 1995; Knoll et al., 1995).  
A decreased temperature of incubation to decrease protein expression and lower the stress 
on the bacterial system may also be necessary (Knoll et al., 1995).  NMTs function well 
at 24oC to 37oC (Knoll et al., 1995) and lowering the temperature to between 24oC and 
30oC in some cases can increase myristoylation by 30% (Van Valkenburgh and Kahn, 
2002).  Therefore, variations in temperature, induction times and inducer concentration 
were examined to determine conditions for optimal myristoylation of hisactophilin. 
In addition to the above growth conditions, the type of myristoyl substrate used 
may also have an affect on incorporation.  A study of recoverin showed an increase in the 
level of myristoylation from 80% with myristic acid to 95% with sodium myristate; in 
addition, the total protein yield also doubled with the use of sodium myristate as opposed 
to myristic acid (Desmueles et al., 2006).  Since myristic acid is insoluble in water it is 
dissolved in ethanol prior to adding to cell cultures; the concentration of ethanol was 
suggested to be a cause for the low protein yields.  Sodium myristate, on the other hand, 
is slightly soluble in water and ethanol is not required.   
 Another reason for possible low levels of myristoylation may be due to both 
plasmids pHW (for hisactophilin expression) and pHV738 (for hNMT1 expression), 
contain promoters which are induced by IPTG (see Figure 2.1 for plasmid maps).  In 
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most cases of proteins that have been successfully myristoylated in E. coli, the target 
protein gene and the NMT gene are controlled by different promoters and use different 
inducing material (Knoll et al., 1995).  Since myristoylation is a co-translational 
modification, the protein NMT must be present and complexed with myristoyl-CoA prior 
to hisactophilin transcription to allow for the modification to occur.  Since both plasmids 
were induced simultaneously, some hisactophilin was not myristoylated.  This problem 
has been encountered previously in a study which attempted to prepare myristoylated 
recoverin (Yonemoto et al., 1993).  This problem has not been overly evident since the 
promoters in this system were somewhat leaky (as was discussed in section 2.3.1).  That 
is, some NMT protein was produced prior to induction of hisactophilin. 
 The use of non-species-specific NMT may also be a reason for incomplete 
myristoylation of proteins (Knoll et al., 1995).  This type of problem has been seen for 
the myristoylation of human Arf proteins (Randazzo and Kahn, 1995; Van Valkenburgh 
and Kahn, 2002).  This incompatibility is possible since, as stated in Chapter 1 (Section 
1.2), the D. discoideum NMT has low sequence homology to both human NMTs and the 
commonly used yeast NMT.  Also, comparing the phylogeny of various NMTs from 
different organisms, the NMT of D. discoideum is quite unique in its structure (Maurer-
Stroh et al., 2002) which may be a reason for decreased levels of myristoylation. 
To separate myristoylated hisactophilin from non-myristoylated hisactophilin 
reverse-phase high pressure liquid chromatography (RP-HPLC) was employed. Previous 
studies have demonstrated that myristoylated and non-myristoylated hisactophilin can be 
resolved using RP-HPLC as illustrated in Figure 3.1 (Hanakam et al., 1995).  The use of 
denaturing organic solvents for protein purification is not often employed; fortunately as 
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shown in this chapter hisactophilin refolds in a non-denaturing buffer with little protein 
loss. 
The level of myristoylation is an important aspect for a large scale preparation of 
myristoylated hisactophilin, but total protein yield is also important.  The growth 
conditions used in the protocol outlined in this chapter yielded relatively high level of 
myristoylation efficiency; however, total protein yield is low.  Preliminary experiments to 
increase the total protein yield were conducted and discussed briefly. The purification 
protocol was examined closely to ensure that there was no significant loss in protein yield 
during each stage of purification. 
 
 TFigure 3.1: TComparison of myristoylated hisactophilin purified from Dictyostelium 
cells (D.d.) with non-myristoylated hisactophilin expressed in E. coli (E.c.). The proteins 
were run under identical conditions on a reversed-phase column with a linear acetonitrile 
gradient. Image from Hanakam et al. (1995).  46
3.2 – Materials and Methods 
 
3.2.1 – Media and Substrate Preparation 
Recombinant protein was prepared, depending upon the application, using rich 
media or M9 minimal media.  Rich media was prepared by dissolving 20g of LB media 
(BioShop Canada Inc., Burlington, ON) in 1L of deionized and distilled water and 
autoclaving for 30 mintues.  M9 minimal media (48mM Na2HPO4, 22mM KH2PO4, 
8.5mM NaCl, 2mM MgSO4, 0.1mM CaCl2, 2% Glucose, 5µg/L Thiamine HCl, 0.5g/L 
NH4Cl) was prepared from a 10x stock solution of M9 salts (480mM Na2HPO4, 220mM 
KH2PO4 and 85mM NaCl) diluted with distilled deionized water and autoclaved.  After 
sterilization of the M9 salts, stock solutions of autoclaved 1M MgSO4 and 0.1M CaCl2 
and stock solutions of filter sterilized (0.2µm filter) 0.05% Thiamine HCl, 20% Glucose 
and antibiotics (final concentration of 100µg/mL ampicillin and 30µg/mL kanamycin) 
were added to the media. Lastly, 0.5g/L of NH4Cl was added directly to the media prior 
to inoculation. 
 Myristoylation substrates were prepared using either myristic acid or sodium 
myristate.  Myristic acid stock solutions were prepared by dissolving myristic acid in 
methanol to a final concentration of 200mM and stored at -20oC until needed.  Sodium 
myristate stock solution was prepared by dissolving sodium myristate in sterilized water 
at 50oC for 1 hour to a final concentration of 20mM.  Sodium myristate solutions were 





3.2.2 – Preparation of Myristoylated Hisactophilin in Rich Media 
To begin the preparation of myristoylated hisactophilin E. coli TG2 or BL21 (non 
DE3, i.e. they lack the T7 polymerase) cells were transformed with pHW1 (hisactophilin) 
and pHV738 (hNMT1+MAP) according to methods outlined in Chapter 2 (see Section 
2.2.3).  Single colonies of the double transformed cells were then used to inoculate 10mL 
of LB media with ampicillin (100ug/mL) and kanamycin (30ug/mL) which was 
incubated at 37oC with 200 rpm shaking overnight.  The entire 10mL overnight culture 
was then used to inoculate 1L of LB media (with ampicillin and kanamycin) which was 
again incubated at 37oC and 200 rpm shaking until the cells had reached an A600 of 
approximately 0.2.  At this point sodium myristate was added to a final concentration of 
200µM and continued incubation.  The culture was incubated for approximately 1 hour 
until it reached mid-log phase with an A600 of 0.7; the cells were then induce with IPTG 
to a final concentration of 1mM.  Cells were allowed to grow for 5-7 hours before 
harvesting by centrifugation at 5000g for 10 minutes at 4oC.  Cell pellets were stored at -
20oC overnight or at -80oC if longer storage times were needed. 
 
3.2.3 – Preparation of Myristoylated Hisactophilin in M9 Minimal Media 
Protein that was prepared in M9 minimal media for 15N labeling was achieved in a 
similar manner as above but with some minor modifications.  Double transformed E. coli 
BL21 cells were used to inoculate 10mL LB (with ampicillin and kanamycin) cultures 
incubated overnight at 37oC with 200 rpm shaking.  The 10mL LB overnight culture was 
then used to inoculate an intermediate culture of 100mL of M9 minimal media (with 
ampicillin and kanamycin and ammonium chloride).  The intermediate culture was 
incubated at 37oC with 200rpm of shaking until it reached an A600 of 0.7.  10mL of the 
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intermediate culture was used to inoculate 1L of M9 minimal media and then incubated at 
37oC with 200rpm of shaking.  Once the culture reached an A600 of approximately 0.4, 
sodium myristate was added to a final concentration of 200µM and incubation continued 
at 37oC.  After approximately 1 hour, the culture reached mid-log phase with an A600 of 
0.7 and was induced with IPTG to a final concentration of 1mM.  Cells were allowed to 
grow for 7 hours before harvesting by centrifugation at 5000g for 10 minutes at 4oC.  Cell 
pellets were stored at -20oC overnight or at -80oC if longer storage times were needed. 
 
3.2.4 – Optimization of Myristoylation 
Optimization of myristoylation and protein yield experiments followed similar 
methods but with modifications in the following parameters: NMT isoforms, growth 
temperature, IPTG concentration, substrate (myristic acid or sodium myristate) and 
substrate concentration.  The protein concentration was determined by absorbance 
measurements at 280nm using an extinction coefficient of 0.330 for a 1mg/mL 
hisactophilin solution (Liu et al., 2001).   
 
3.2.5 – Purification of Myristoylated Hisactophilin 
All of the optimization experiments used the following for protein purification 
protocol.  The harvested cells (from 3L of media) were resuspended on ice in 25-50mL of 
buffer A (20mM Tris pH 8.0, 1mM EDTA).  Cells were lysed using an EmulsiFlex-C5 
homogenizer (Avestin Inc., Ottawa, ON) at a pressure of at least 17000psi according to 
the manufacturer’s directions.  To extract membrane-bound hisactophilin, the lysate was 
incubated with 0.5% CHAPS (BioShops Canada Inc.) with constant stirring at 4oC for 2 
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hours.  After incubation the cell debris was collected by centrifuging the lysate at 50000g 
for 25 minutes at 4oC.  The supernatant was collected and filtered using a 0.4µm filter.   
 Initially, a crude purification of the protein is achieved by anion exchange 
chromatography.  Anion exchange chromatography was performed at 4oC.  The 50mL 
cell lysate was loaded at 3mL/min onto a self-packed 2.5×50cm DEAE-Sepharose Fast 
Flow (Sigma Chemical Company, St. Louis, MO) anion exchange column pre-
equilibrated with 2L of buffer A (20mM Tris pH 8.0, 1mM EDTA) using the BioLogic 
LP chromatography system (Bio-Rad Laboratories, Hercules, CA).  The column was 
washed with 90mL of buffer A at 2mL/min.  The protein was eluted using a 0-100% 
buffer B (20mM Tris pH 8.0, 1mM EDTA and 400mM NaCl) linear salt gradient over 
700mL at 2mL/min.  Hisactophilin elutes between 140-240mM NaCl.  Fractions 
identified by SDS-PAGE to contain hisactophilin were collected and concentrated to 
approximately 7.5mL using a 3kDa cutoff YM-3 Amicon (Millipore, Billerica, MA) 
filter. 
 The second step of purification was achieved using size exclusion 
chromatography.  A 5×60cm G75-Superdex Size Exclusion column (Pharmacia, 
Piscataway, NJ) was equilibrated with 1 column volume (approximately 300mL) of size 
exclusion buffer (150mM Tris pH 8.0, 1mM EDTA, 1mM DTT) using a BioCad Sprint 
Perfusion Chromatography System  (Perceptive BioSystems, Ramsey, MN).  The 
concentrated fractions from anion exchange chromatography were diluted to 15mL with a 
2× size exclusion buffer and injected onto the column over 3 injections using a 5mL loop.  
The protein was eluted with size exclusion buffer at 3ml/min.  Fractions identified by 
SDS-PAGE to contain hisactophilin were exchanged into ultra pure water using a 1000× 
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dilution with a 3kDa cutoff YM-3 Amicon filter and the protein was concentrated to 
15mL using the Amicon filter.  The protein was further concentrated to 1mL using a 
3kDa cutoff YM-3 Centriprep® Centrifugal Filter (Millipore).   
 To separate myristoylated hisactophilin from non-myristoylated hisactophilin 
reverse phase HPLC was employed.  The protein was loaded onto a Bondapak RPC18 
column (15-20µm 25x100mm) (Waters, Milford, MA) using a Waters 600 HPLC Pump 
and Gradient Controller equipped with a 996 Photodiode Array Detector (Waters) and a 
1mL sample loop.  The column was pre-equilibrated with 5-10 column volumes (250-
500mL) of a 98:2 mixture of solvent A (0.1% trifluoracetic acid in water) and solvent B 
(0.1% trifluoracetic acid in acetonitrile).  Protein was eluted at a flow rate of 10mL/min 
with a linear gradient of 2-62% B in A over 60 minutes (i.e. 1% per minute).  The eluted 
myristoylated protein was collected and immediately dialyzed against 25mM ammonium 
carbonate, concentrated with a 3kDa cutoff YM-3 Amicon filter and flash frozen in liquid 
nitrogen.  Protein was stored at -80oC. 
 Calculation of percent yield after each stage of purification was achieved 
collecting aliquots of each stage and analyzed by SDS- PAGE as outlined in Section 
2.2.5.  The intensity of bands for each lane was then analyzed and peaks corresponding to 
hisactophilin were integrated using the ImageJ (U. S. National Institutes of Health, 
Bethesda, MA) software package. 
 
3.2.6 – Circular Dichroism Spectroscopy 
  
 CD measurements were performed using a J715 spectrapolarimeter (Jasco Inc., 
Easton, MD) with a 1mm path-length cuvette.  Temperature was kept constant at 25oC 
using an Elfin Model ELDC5D4 Peltier-controlled sample cell (Jasco Inc. Easton, MD).  
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Protein samples were prepared by dialyzing into 25mM ammonium carbonate (after RP-
HPLC) and dilution to a final protein concentration of 20µM (0.25mg/mL).  Denatured 
samples were prepared using lyophilized protein reconstituted in 20mM acetic acid at the 
same concentration.  Scans were acquired with 1mm path-length cuvette over a 
wavelength range of 280-190nm with a step of 0.5nm; data were collected as an average 
of 5 scans and no further processing was completed. 
 
3.2.7 – Mass Spectrometry 
 Mass spectrometry samples were prepared by diluting a 2× protein sample in H2O 
with a 0.4% TFA in acetonitrile for a final protein concentration of approximately 7µM.  
Samples were analyzed using a Micromass Q-TOF UltimaTM Global instrument (supplied 




3.3 – Results and Discussion 
 
 
3.3.1 – Purification of Recombinant Myristoylated Hisactophilin 
Previously, purification of recombinant non-myristoylated hisactophilin was 
achieved using a two step process consisting of DEAE anion exchange chromatography 
followed by size exclusion chromatography (Liu, 1999).  With the incorporation of a 
myristoyl group into the protein, it was necessary to add an additional reverse phase 
HPLC purification step.  This purification step is necessary to separate myristoylated 
hisactophilin from non-myristoylated hisactophilin since not all hisactophilin produced 
was myristoylated.  Incomplete myristoylation may be caused by the leaky expression of 
hisactophilin as well as incompatibilities of hNMT with hisactophilin (as discussed 
above).  
Both myristoylated and non-myristoylated hisactophilin co-elute during anion-
exchange chromatography at a relatively low salt concentration.  Figure 3.2 illustrates 
that both forms of the protein co-elute at between 140-220 mM salt.  The fractions 
collected during this first step of purification show only the presence of a small number 
of high molecular weight proteins remain.  These high molecular weight proteins are 
easily separated from hisactophilin using size exclusion chromatography. This second 
stage of protein purification yields a highly pure mixture of myristoylated and non-
myristoylated hisactophilin.  The myristoyl group only adds an additional mass of 228Da 
to the protein which did not to allow for differentiation of the two forms of the protein by 




















































Figure 3.2: DEAE anion exchange elution profiles for myristoylated hisactophilin 
preparation.  (A) Typical elution profile of myristoylated hisactophilin from whole cell 
lysate. (B) Elution of a standard pure non-myristoylated hisactophilin sample.  Arrows 
indicate the location of hisactophilin. 
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Figure 3.3: Size exclusion chromatography for the purification of hisactophilin.  
The elution curves are from a purification of (A) non-myristoylated hisactophilin 
and (B) myrisotylated hisactophilin.  Arrows indicate that the elution of both 
myristoylated and non-myristoylated protein are the same with a retention time 
of 103 minutes. 
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Furthermore in SDS-PAGE both myristoylated and non-myristoylated forms of 
the protein migrate at the same rate (Figure 3.4A).  Likewise, native PAGE also shows no 
differences in the manner in which they migrate (Figure 3.4B).  The gels, along with the 
above purification protocol, are a good indication that the presence of the myristoyl group 
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Figure 3.4: Fractions collected from DEAE anion exchange column.  (A) Two different 
fractions were analyzed by SDS-PAGE for both non-myristoylated (Non-Myr) and 
myristoylated (Myr) hisactophilin preparations.  Each fraction shows a number of higher 
molecular weight proteins which were separated by size exclusion chromatography. (B) 
Same fractions run on a native-PAGE.  Note that neither SDS- or native-PAGE show 
different migration for myristoylated and non-myristoylated protein. MW represents the 
molecular weight marker. 
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Separation of myristoylated and non-myristoylated forms of the protein was 
initially attempted, unsuccessfully, under non-denaturing conditions by hydrophobic 
interaction chromatography (results not shown).  However, the denaturing conditions of 
C18 reverse-phase HPLC proved to be sufficient for the separation.  This method of 
separation has been employed for the purification of other myristoylated proteins which 
have low-efficiency of myristoylation (Hughes et al., 1995).  In the reverse-phase HPLC 
elution profiles of myristoylated hisactophilin there are three well resolved peaks with a 
retention time between 30 and 45 minutes (Figure 3.5A).  The non-myristoylated form of 
the protein elutes with a retention time of 33.2 minutes, whereas, the myristoylated form 
of the protein has a retention time of 43.1 minutes; these retention times  are similar to 
those found previously by Hanakam et al. (1998) and was confirmed by mass 
spectrometry (Appendix 1).  The myristoylated form of the protein will have a much 
higher hydrophobicity due to the myristoyl group and therefore will elute later.  The third 
peak in the elution profile has a retention time of 40.3 minutes and is most likely 
hisactophilin that has been modified with an acyl chain other than myristate.  The activity 
of hNMT is not highly selective for myristoyl CoA and may attach other fatty acids 
(Bhatnagar et al., 1999).  This elution profile was also observed protein was prepared 
without excess sodium myristate (i.e. hisactophilin preparation using dual transformed 
system without adding sodium myristate).  Although myristic acid is a rare cellular fatty 
acid, E. coli has some endogenous myristic acid available for myristoylation to occur in 
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Figure 3.5: C18 RP-HPLC purification of hisactophilin.  (A) Myristoylated hisactophilin preparation 
with hNMT2 indicating retention times for non-myristoylated protein (33.2min), acylated protein 
(40.3min) and myristoylated protein (43.1min).  (B) Hisactophilin preparation with hNMT2 but no 
additional myristic acid substrate indicating same retention times as A; myristoylated protein has a 
much lower incorporation rate.  (C) Non-myristoylated hisactophilin preparation indicating elution of 
only non-myristoylated protein (33.2min). 5833.233.33.240.340.43.43. 
In this case (Figure 3.5B), the elution profile still shows the presence of three well 
resolved peaks corresponding to non-myristoylated hisactophilin, myristoylated 
hisactophilin and a third acylated hisactophilin.  Only when hisactophilin is prepared 
using a system lacking NMT (Figure 3.5C), there is one distinct peak corresponding to 
the non-myristoylated form of the protein.  
It was important to ensure that after separating denatured myristoylated and non-
myristoylated forms of hisactophilin by reverse phase chromatography that the protein 
can refold to its native state in a non-denaturing buffer.  Non-myristoylated hisactophilin 
has been shown previously to refold with high reversibility under many solution 
conditions (Lui et al, 1999).  The refolding of myristoylated hisactophilin was verified, 
initially by circular dichroism spectroscopy, and later confirmed by NMR (see Section 
4.3).  In most cases, the myrsitoylated and non-myristoylated forms of a protein yield 
nearly identical CD spectra (Resh, 1999), which is also true for hisactophilin (see Figure 
1.13 for CD spectra of myristoylated and non-myristoylated hisactophilin) (Hanakam, 
1996).  From Figure 3.6 it is clear that hisactophilin undergoes renaturation after dialysis 
into non-denaturing buffers. 
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 Denatured Hisactophilin Mixture
 Myristoylated Hisactophilin
 Non-myristoylated Hisactophilin
Figure 3.6:  Circular Dichroism Spectra of myristoylated, non-myristoylated and 
denatured hisactophilin.  Results are displayed as raw CD (A.U.) data with no 
processing.  Myristoylated and non-myristoylated scans are nearly identical.  In 
addition, dialyzing protein into ammonium carbonate causes the protein to refold after 
exposure to the denaturing conditions of C18 RP-HPLC. 
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3.3.2 – Optimization of Myristoylation and Total Protein Yield 
 
Reverse phase HPLC was required for the purification, but also provides a means 
to monitor levels of myristoylation.  The myristoylation levels were simply determined 
by integrating the area of the peaks within the elution curve to calculate the percent 
myristoylation.  This, along with yield of purified protein, was used to determine 
conditions for obtaining the best possible yield of myristoylated hisactophilin from this 
system by manipulating a number of different growth parameters.  The parameters 
investigated included: growth temperature, IPTG concentration, NMT isoform, substrate, 
substrate concentration and growth media.  The results of these optimization experiments 
are summarized in Table 3.1 and are further discussed below. 
 
3.3.2.1 – Growth Temperature 
In some cases levels of protein myristoylation have been increased significantly 
by lowering the growth temperatures (Van Valkenburgh and Kahn, 2002).  For 
hisactophilin, a decrease in the growth temperature for the cells caused a significant 
decrease in the level of myrisoylation.  Protein prepared at 37oC (with hNMT2, 200µM 
myristic acid and 1mM IPTG) was 22% myristoylated, which decreased to 15% at 30.5oC 
and as low as 5% at 24oC (Figure 3.7A and 3.8).  In most cases a decrease in temperature 
will slow down protein expression, which in turn puts less stress on the cells and allows 
for an increased level of myristoylation (Van Valkenburgh and Kahn, 2002).   
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Table 3.1: Summary of all growth parameters tested for optimization of myristoylation of hisactophilin 
Growth Parameters 
















TG2           LB hNMT2 Myristic Acid 200 37 1 7 22 27 5.8
TG2           LB hNMT2 Myristic Acid 200 30.5 1 10.5 17 33 5.6
TG2           LB hNMT2 Myristic Acid 200 24 1 13.5 5 48 2.4
TG2           LB hNMT2 Myristic Acid 200 37 0.5 10 17 24 4.0
TG2           LB hNMT2 Myristic Acid 200 37 0.25 10 19 20 3.8
TG2           LB hNMT2 Myristic Acid 200 37 0.1 12 4 14 0.6
TG2           LB hNMT2 Myristic Acid 200 24 0.1+0.1 12 2 16 0.3
TG2           LB hNMT1 Myristic Acid 200 37 1 4 49 7.8 3.8
TG2           M9 hNMT1 Myristic Acid 200 37 1 5 12 3.3 0.4
BL21          LB hNMT1 Sodium Myristate 200 37 1 4 84 13.6 11.4
BL21          M9 hNMT1 Sodium Myristate 200 37 1 7 58 5.7 3.3
BL21          M9 hNMT1 Sodium Myristate 80 37 1 7 56 5.6 3.2
























































































































































Figure 3.7: Optimization of 
myristoylation for hisactophilin.  
(A) optimization of temperature. 
(B) Optimization of IPTG 
concentration.  It appears to have 
the highest incorporation of 
myristoyl along with highest 
protein yield cells should be grown 
at 37PoPC and induced with 1mM 
IPTG.  
Figure 3.8: HPLC Elution 
profiles of myristoylated 
hisactophilin preparation at 
various temperatures.  
Myristoylation levels decrease 
with temperature.  Also note that 
at 24PoPC has a different elution 
profile as described in the text
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In addition to a decreased level of myristoyl incorporation at 24oC, RP-HPLC 
elution curves also showed the presence of additional contaminating peaks with retention 
times around 40 minutes (Figure 3.8C).  These additional peaks may be caused by the 
incorporation of a number of different acyl chains other than myristic acid being 
incorporated into the protein by NMT.   
 
3.3.2.2 – IPTG Concentration 
For a similar reason as above for temperature, the concentration of IPTG added to 
induce the production of protein influences the levels of myristoylation.  A decrease in 
IPTG concentration caused a decrease in the levels of myristoylation.  Protein prepared 
with 1mM IPTG (with hNMT2, 200µM myristic acid and at 37oC) showed the highest 
level of incorporation of 22% whereas decreasing IPTG to 0.1mM decreased the 
incorporation to a mere 4%.  However, a two-fold decrease in IPTG concentration to 
0.5mM resulted in only minor suppression of myristoylation with levels of incorporation 
at 17% and further decrease to 0.25mM IPTG gave a myristoylation level of 19% (Figure 
3.7B).  This implies that the concentration of IPTG above 0.25mM does not have a large 
affect on the level of myristoylation. 
 
3.3.2.3 – NMT Isoform 
Although the hNMT2 system could be used for preparing myristoylated 
hisactophilin (as shown in Section 2.3.2) it gave rather low levels of incorporation.  
Hisactophilin prepared with hNMT2 (200µM myristic acid, 1mM IPTG and at 37oC) had 
only 22% incorporation (Figure 3.9A).  On the other hand, the hNMT1 system (200µM 
myristic acid, 1mM IPTG and at 37oC) gave a much higher level of myristoylation at 
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49% (Figure 3.9B).  Unfortunately, from preliminary results the system using hNMT1 
has a much lower total protein yield.  These results were calculated from a single 
purification and were allowed to grow for different induction times therefore these values 
need to be verified by further experimentation. 
 
3.3.2.4 – Myristoyl Substrate 
The use of myristic acid as a substrate has a two-fold negative impact on the level 
of myristoylation.  According to studies on the preparation of myristoylated recoverin, 
the methanol used to solubilize myristic acid decreases total protein yield and, 
additionally, water soluble sodium myristate has a higher efficiency of incorporation 
(Desmueles et al., 2006).  This study also shows an increase in both total protein yield 
and level of myristoylation when using sodium myristate as opposed to myristic acid.  
The level of myristoylation increases from 49% with myristic acid to 84% with sodium 
myristate (Figure 3.9C and Table 3.1).  Likewise, the total protein yield increases total 









Figure 3.9: HPLC elution curve of myristoylated hisactophilin for various growth 
conditions.  (A) Co-expression system with hNMT2 and myristic acid (22% 
myristoylation), (B) Co-expression system with hNMT1 myristic acid (49% 






3.3.2.5 – M9 Minimal Media 
Detailed structural analysis of myristoylated hisactophilin (described in the 
following chapter) required the preparation of 15N-labeled protein.  15N-labeled 
myristoylated hisactophilin was prepared by combining the above procedure for 
preparing myristoylated protein with established procedures for preparing 15N-labeled 
non-myristoylated hisactophilin using 15N-enriched minimal media (Houliston, 2002).  
Using M9 minimal media (containing 15N-labeled ammonium chloride as the sole 
nitrogen source) also had an impact on the level of myristoylation and the total protein 
yield.  The use of M9 minimal media caused the level of myristoylation to drop to 58% 
incorporation as opposed to 84% when grown for rich LB media.  In addition, minimal 
media only yields 3.3 mg of total protein per 1L of media.  Although it would be 
preferable to have a higher yield, this yield was sufficient to pursue NMR studies, 
described in the next chapter. 
 
3.3.3 – Percent Yield for Purification Stages of Myristoylated Hisactophilin 
 In order to ensure that the protocol outlined for the purification of myristoylated 
hisactophilin the total protein percent yield for each stage of purification was checked.  
As there is no simple activity assay available, the percent yield for each stage of 
hisactophilin purification was measured by monitoring SDS-PAGE band intensities.  At 
each stage of purification an aliquot was taken.  Analysis of band intensity shows that for 
both preparation in rich LB media (Figure 3.10) and M9 minimal media (Figure 3.11) 
have minor loss of the total protein during each stage of purification detailed in Table 4.2.  
RP-HPLC has, as expected, a much higher loss of protein since only 85% in rich media 
and 58% in minimal media was myristoylated.
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5 Figure 3.10: Percent yield determination 
for myristoylated hisactophilin 
purification in rich LB media.  Above 
shows the gel of each stage of 
purification collected. Right is the 
histogram of the band intensity for each 
corresponding lane of the gel.   The 
stages of purification are: (1) whole 
harvested cells, (2) cell lysate, (3) 
fractions from DEAE anion exchange, 
(4) dialysis into size exclusion buffer, (5)
fractions from size exclusion, (6) dialysis













5 Figure 3.11: Percent yield determination 
for myristoylated hisactophilin 
purification in M9 minimal media.  Above
shows the gel of each stage of purification 
collected. Right is the histogram of the 
band intensity for each corresponding lane
of the gel.   The stages of purification are: 
(1) whole cells, (2) cell lysate, (3) 
fractions from DEAE anion exchange, (4) 
dialysis into size exclusion buffer, (5) 
fractions from size exclusion, (6) fractions





Table 3.2: Purification of myristoylated hisactophilin in LB and M9 minimal media  
Rich LB Media 
Stage of Purification % Area from Integrationa
Total Hisactophilin 
(mg/1L of cells) % Yield 
1 Whole cells 22.7 23.0 100 
2 Cell lysate 20.7 21.2 91.2 
3 DEAE anion exchange 17.3 18.4 76.3 
4 Dialysis 1b 12.9 15.5 57.1 
5 Size exclusion  10.5 14.0 46.5 
6 Dialysis 2c 9.3 13.2 40.9 
7 RP-HPLC 5.6 11.4 24.8 
M9 Minimal Mediac
1 Whole cells 20.6 6.9 100.0 
2 Cell lysate 18.7 6.3 91.0 
3 DEAE anion exchange 14.2 5.2 69.2 
4 Dialysis 1b 12.3 4.8 59.6 
5 Size Exclusion 11.2 4.5 54.5 
7 RP-HPLC 3.6 3.3 17.4 
a Values are calculated from an average of two separate purifications 
b First dialysis into size exclusion buffer 
c Second dialysis into water; this was not collected for the M9 minimal media purification 
 
   
 The purification of protocol outlined has only minor losses of protein for each 
stage of purification.  For each purification (LB rich media and M9 minimal media) cell 
lysis showed an approximately 10% loss of protein.  This is similar for the dialysis steps, 
which is most likely caused by protein sticking to the filter membranes used.  DEAE 
anion exchange chromatography has the highest level of protein loss at nearly 20%.  On 
the other hand, RP-HPLC looses very little protein as the loss of protein is caused by 
separation of non-myristoylated from myristoylated protein.
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3.4 – Summary  
 
Overall, the optimization experiments undertaken yielded a protocol with 
relatively high levels of myristoylation (86%); unfortunately, this protocol also had low 
total protein yield.  Further optimization experiments could be undertaken using hNMT2 
which may have given higher total protein yield but low myristoylation levels.  However, 
this protocol does produce sufficient amounts of protein for characterization of the effects 
of myristoylation of hisactophilin. 
To extract structural effects of myristoylation of hisactophilin using NMR 
methods the protein must be uniformly 15N-labeled.  To achieve this labeling, E. coli 
BL21 cells carrying the pHW plasmid and the hNMT plasmid need to be grown in M9 
minimal media.  To ensure proper labeling, 15NH4Cl is used as the sole nitrogen source.  
These modifications to the protocol outlined above for the myristoylation of hisactophilin 
will yield uniformly 15N-labeled hisactophilin with a covalently-bound, myristic acid 
group.  Although it would be preferable to have a higher yield preparing protein in M9 





CHAPTER 4 – EFFECTS OF MYRSITOYLATION ON THE STRUCTURE AND 
STABILITY OF HISACTOPHILIN 
 
4.1 – Introduction 
 
4.1.1 – Nuclear Magnetic Resonance of Myristoylated Hisactophilin  
 
The structural changes incurred by the myristoylation of hisactophilin were 
monitored by multidimensional, multinuclear solution NMR.  To determine structure by 
solution NMR, relatively high concentrations (in the mM range) of protein are needed, 
and thus the protein being studied must be highly soluble.  Non-myristoylated 
hisactophilin is sufficiently soluble for NMR experimentation (Habazettl et al., 1992a); 
also, myristoylated hisactophilin is likely to be sufficiently soluble since it can be found 
in rather high concentrations in the cytosol (Hanakam et al., 1995).  However, during 
preparation of myristoylated hisactophilin samples the solubility appears very low at a pH 
below 6.7; above this pH we are able to prepare relatively concentrated solutions of 
myristoylated protein sufficient for NMR experiments. 
 The first step in determining the structure of a protein by NMR is the 
determination of sequence specific resonance assignments.  In most cases, resonance 
assignments are determined through a variety of multidimensional and multinuclear 
NMR experiments (Bax et al., 1994; Kay, 1997).  However, since the structure of non-
myristoylated hisactophilin has already been solved by NMR, the resonance assignments 
have already been determined and are available.  The assignments were made using 1H 
and 15N homo- and heteronuclear multi-dimensional methods (Habazettl et al., 1992b) 
which were also sufficient for the sequence specific resonance assignments for 
myristoylated hisactophilin.   
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 The known resonance assignments for non-myristoylated hisactophilin were very 
useful as a starting point for assigning the myristoylated form, since numerous 
resonances had similar chemical shifts in both forms of the protein.  The assignments for 
myristoylated hisactophilin will provide the basis for analyzing the structural 
consequences of myristoylation by NMR.  The most important of these structural data are 
distance restraints determined by NOESY (Van Holde, 1998).  These distance restraints 
are obtained from NOESY cross-peaks that arise from spins that are far apart in sequence 
but close enough (within 5Ǻ) structurally to allow for the through-space NOE interaction 
(Wuthrich, 1986).  Also, a great deal can be determined from NOE experiments about the 
secondary-structure of the protein.  Each of the different secondary structures that are 
present within proteins yields characteristic patterns of repeating NOE cross-peaks 
(Wuthrich, 1986). For example, β-strands will have relatively strong sequential CαH/NH 
cross-peaks (Van Holde, 1998).  This information on secondary structure is useful for the 
comparison of the two forms of the protein.  Also, NOE crosspeaks for the methyl of the 
myristoyl group will be of particular interest for defining the location of the myristoyl 
group in the protein. 
 It is expected that the membrane binding properties of hisactophilin operate in 
conjunction with some type of myristoyl switch that is most likely pH dependent 
(Hanakam et al., 1996b).  The presence of this switch was determined by monitoring the 
structure of myristoylated hisactophilin over a variety of different pH values.  As the pH 
is varied, the structure of hisactophilin may change as the myristoyl switch moves from 




4.1.2 – Stability of Myristoylated Hisactophilin 
The final stages of this project were to determine the stability and folding of 
myristoylated hisactophilin.  The conformational stability of a protein is determined 
through denaturation by comparing the free energy of the folded state with the free 
energy of the denatured state.  The conformational stability of the protein may then be 
defined as the change in free energy for the following equation: 
)(denatured unfolded(native) folded ↔  
The conformational stability of a protein is then defined as ∆G(H2O) for chemical 
denaturation and ∆G(25OC) for thermal denaturation (Pace et al., 1989).   
The stability and folding of non-myristoylated hisactophilin have been determined 
previously (Liu et al., 2001).  The stability of the myristoylated protein was investigated 
using similar methods to those described by Liu et al. (2001).  The thermodynamic 
stability of myristoylated hisactophilin was determined using urea denaturation curves.  
Urea-induced unfolding of hisactophilin was monitored by far-UV CD measurements.  In 
order to perform denaturation experiments of myristoylated hisactophilin, the 
denaturation process must be at equilibrium and must be reversible, as is required for all 
thermodynamic measurements (Pace et al., 1989).  Liu et al. (2001) have determined that 
urea induced unfolding of non-myristoylated hisactophilin is greater than 90% reversible 
while thermal denaturation is at least 80% reversible (Liu et al., 2001).  This data were 
then used to compare the stability of myristoylated hisactophilin to non-myristoylated 
hisactophilin as well as the stability of other β-trefoil proteins.  To monitor the physical 
properties of the protein during urea denaturation, many different optical probes may be 
used, such as UV difference spectroscopy, fluorescence, CD, or NMR (Pace, 1986).  
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However, for this study, only preliminary denaturation experiments using CD have been 
completed.   
 
4.1.3 – Circular Dichroism Spectroscopy 
Secondary structural changes occurring during urea denaturation can be 
monitored conveniently using CD spectroscopy.  This technique exploits the optical 
activity that arises in small molecules due to the presence of asymmetric carbons 
(Woody, 1996).  The optical activity associated with proteins is highly dependent upon 
the molecular conformation (Woody, 1996).  Since this technique is sensitive to the 
molecular conformation of the peptides, it is also sensitive in monitoring changes in 
secondary structure of proteins (Manning, 1989). Monitoring these changes in secondary 
structure caused by denaturing the protein will be used to produce denaturation curves. 
 Monitoring denaturation by CD utilizes a polarization of light known as circular 
polarized light to determine the secondary structure of a peptide (Woody, 1996).  Circular 
polarized light, unlike planar polarized light, rotates with the frequency of the radiation 
(Woody, 1996).  This type of polarized light can be rotating in either a clockwise or 
counterclockwise direction and is labeled by convention as right-circular polarized and 
left-circular polarized light respectively (Woody, 1996).   
Most biological macromolecules have optical activity which will cause them to 
absorb only one direction of circular polarized light (Woody, 1996).  During an 
experiment, a sample is exposed to alternating left- and right-circular polarized light and 
the absorbance of each is measured (Manning, 1989).  The difference in these 
absorbencies is defined as the circular dichroism (∆A).  When the CD is collected over a 
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range of wavelengths in the far UV, (~180-260nm) it will produce a CD spectrum which 
is unique to the secondary structure of that protein (Berndt, 1996). 
  Native non-myristoylated hisactophilin has a characteristic CD spectrum similar 
to what is expected of an all β-protein (Figure 4.1).  The native spectrum (no denaturant) 
contains broad minima at 209nm and 200nm and a maximum at 227nm (Liu et al., 2001).  
The CD spectrum of native non-myristoylated hisactophilin is nearly identical to that of 
myristoylated hisactophilin (as was seen in the previous chapter Figure 3.5) (Liu et al., 




Figure 4.1 – CD Spectra of non-myristoylated hisactophilin. 
Spectra obtained of protein  in 0M Urea (solid line), 3M urea 
(dashed line) and 8M urea (dotted line) (Liu et al., 2001) 
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4.2 – Materials and Methods 
 
4.2.1 – Protein Preparation  
Protein was prepared as described in section 3.2.3 and purified as described in 
section 3.2.6 with the following modifications for preparation of 15N-labelled protein.  
Protein used in 15N-edited NMR experiments was prepared using minimal media with 
unlabeled NH4Cl in the intermediate culture and 0.5g/L of 15NH4Cl (Cambridge Isotope 
Laboratories, Andover, MA) added directly to 1L growth cultures.  Following 
purification protein was lyophilized in 25mM ammonium carbonate.   
Unlabeled myristoylated and non-myristoylated (prepared as before without co-
expression or RP-HPLC) protein samples for homonuclear NMR experiments were 
prepared by dissolving 15mg of unlabeled lyophilized protein in 500µL of 50mM 
potassium phosphate buffer at pH 6.7 with 10% D2O; this produced a final protein 
concentration of 2.2mM and a final pH of 6.78 for the myristoylated protein and 6.81 for 
the non-myristoylated sample.  A second myristoylated sample was prepared with the 
same parameters as above using 100% D2O for amide exchange information. 
15N-labeled protein for heteronuclear experiments was prepared by dissolving 
19.5mg of lyophilized protein in 500µL of 50mM potassium phosphate buffer at pH 6.7 
with 10% D2O; the final protein concentration was 2.9mM and a final pH of 6.81.  
Sample pH was determined using a Calomel Glass Micro pH Electrode (Thermo Electron 






4.2.2 – NMR 
All NMR experiments were performed using at 303.0K on a Bruker Avance 
DMX 600MHz spectrometer equipped with an inverse 1H/13C/15N triple resonance xyz 
gradient probe (Bruker, Billerica, MA)  
 
4.2.2.1 – 1H Homonuclear NMR of Myristoylated and non-Myristoylated Hisactophilin 
 One dimensional homonuclear spectra were obtained using excitation sculpting 
for water suppression for all protein samples (Hwang and Shaka, 1995). 1H-1H TOCSY 
experiments were conducted with a τm of 46.04ms (16 cycles) for both myristoylated and 
non-myristoylated hisactophilin.  A total of 64 scans were performed collecting 4096 
points in the direct dimension and 512 points in the indirect dimension.  1H-1H NOESY 
experiments were conducted with a τm of 125ms for both myristoylated and non-
myristoylated hisactophilin.  A total of 80 scans were performed collecting 4096 points in 
the direct dimension and 512 points in the indirect dimension.  Complete pulse sequences 
can be found in Appendix 2. 
 
4.2.2.2 – Multidimensional Heteronuclear NMR of Myristoylated Hisactophilin  
3D 15N-edited TOCSY experiments were performed using a τm of 55.25ms (9 
cycles).  3D 15N-edited NOESY experiments were performed using a τm of 150ms.  
Detailed pulse sequences can be found in Appendix 2. 
 HSQC spectra were obtained at various pH values by titrating 15N-labeled protein 
with 0.5M NaOH (BioShops).  Approximately 4-10uL of NaOH was needed to raise the 
pH by 0.2-0.4 pH units; HSQC spectra were obtained at pH values of 6.81, 7.04, 7.24, 
7.67 and 8.01.   
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4.2.3 – Analysis of NMR Data 
All NMR data was processed using Felix97 Software (MSI Inc.) using an Indigo 
II workstation (Silicon Graphics, Increase).  A square sinebell apodization function was 
applied to the directly acquired dimension.  Indirect dimension were linear predicted to 
twice the original data size, a square sine bell function was applied to the resulting 
indirect FID and zero filled to the nearest 2n data points.  
Sequence specific resonance assignments were completed with CARA v.1.8.1 
developed by the Institute of Molecular Biology and Biophysics at ETH Zurich. The free 
software can be downloaded from http://www.nmr.ch.  All protein figures were created 
using MolMol 2K.2 (Institute of Molecular Biology and Biophysics at ETH, Zurich). 
 
4.2.4 – Chemical Denaturation of Myristoylated Hisactophilin 
 Denaturation curves were prepared at different pH values by unfolding 
myristoylated hisactophilin in a series of urea concentrations.  A 9M urea (BioShops) 
stock solution was prepared gravimetrically in a volumetric flask and stored until needed 
at -80oC.  All buffers were prepared gravimetrically in volumetric flask using glycine 
(BioShops) for pH 8.7, potassium phosphate (BioShops) for pH 7.7 and 6.7 and MES 
(Sigma) for pH 5.7.  A 10× protein stock solution was prepared by dissolving lyophilized 
protein in the appropriate buffer.  The protein solution was then diluted in a combination 
of urea and water to yield a final protein solution of 0.2mg/mL myristoylated 
hisactophilin in 50mM buffer, 1mM EDTA (BioShops), 1mM DTT (Bioshops) and 
desired urea concentration ranging between 0-9M as outlined in Appendix 3.  The 
samples were allowed to equilibrate for approximately 3 hours before taking CD 
measurements at 227nm in a 1mm cuvette on a J715 spectrapolarimeter (Jasco Inc.) at 
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25oC.  Midpoints were calculated by fitting data to a two state model using OriginPro 




4.3 – Results and Discussion 
 
 
4.3.2 – Structural Studies of Myristoylated Hisactophilin  
Although the 1D proton NMR spectra of proteins are rather crowded, some 
structural data can often be extracted.  A comparison of 1D proton NMR spectra of 
myristoylated and non-myristoylated hisactophilin (Figure 4.2) shows similar dispersion 
of signal with some obvious differences.  Firstly, well resolved downfield amide peaks 
(10.0ppm to 11.0ppm) move upon myristoylation.  The spectrum for the non-
myristoylated protein shows four well-resolved peaks which have previously been 
assigned to the amide protons of I85 (δ 10.375ppm), L45 (δ10.273ppm), F6 (δ 
10.130ppm) and S8 (δ10.017ppm).  Figure 4.3 illustrates the amide protons of I85, L45 
and F6 are situated on β-strands 9, 5 and 1 (which are all part of the beta barrel) and are 
on the interior of the protein.  S8 also faces the interior of the protein but is in a turn 
connecting β-strands 1 and 2. The downfield shift of these protons is most likely caused 
from heavy hydrogen bonding in β-strands and in a turn.  In contrast, the spectrum of the 
myristoylated protein shows only two well resolved peaks in this region with one peak 
shifted further downfield (δ 10.706ppm) than any peaks for the non-myristoylated form.  
Since I85, L45 and F6 are located on β-strands this would suggest that there is a change 
in the hydrogen bonding network of the beta barrel caused by myristoylation of the 
protein.  Although it appears that I85, L45 and F6 have shifted significantly it appears 
that the peak corresponding to S8 of the non-myristoylated protein remains unchanged; 
this suggests that S8 does not have a significant change due to myristoylation of the 
protein.  Although all of these residues face the core of the protein, S8 is not located 
within the beta-barrel but is located in a turn.  
Figure 4.2: Comparison of 1D NMR spectra of (A) non-myristoylated hisactophilin and (B) myristoylated hisactophilin. 




I85 L45 F6 S8 
A 
B 
Figure 4.3: Ribbon diagram of non-myristoylated hisactophilin highlighting various 
residues.  The figure shows (A) a bottom view of the protein looking down the beta 
barrel and (B) a side view of the protein.  Residues highlighted are F6 (red), S8 
(green), L45 (yellow) and I85 (blue).  Figure was created with MolMol using pdb code 
1hcd. 
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Since S8, is not affected by myristoylation this indicates that there is a change in the 
packing of the beta-barrel and, most likely, not a significant change in the packing of the 
hairpin triplet – although this is difficult to interpret from only one residue and is further 
addressed by heteronuclear experiments (see below). 
In addition to well defined downfield peaks, both 1D 1H spectra share a well 
resolved peak upfield at approximately -0.8ppm.  Previous assignments for non-
myristoylated hisactophilin have indicated that this peak arises from the δCH3 group of 
I85 located within the core of the beta barrel.  Methyl groups are expected to resonate in 
the range of 0-2ppm (Wuthrich, 1989).  Analysis of the structure of non-myristoylated 
hisactophilin shows that I85 is situated close to the aromatic ring of F6 and due to ring 
current shifts the δCH3 peak resonates significantly upfield.  Since this peak does not 
shift significantly upon myristoylation the δCH3 of I85 likely remains packed near the 
ring of F6.  The spectrum of the non-myristoylated protein has one upfield peak at -
0.803ppm; however, an obvious difference is the presence of two upfield peaks with a 
chemical shift of -0.732ppm and -0.824ppm in the spectrum of myristoylated 
hisactophilin.  These two peaks are not a splitting of the single peak found in the 
spectrum of non-myristoylated hisactophilin.  Since these peaks resonate upfield similar 
to the δCH3 of I85, it is likely that these protons are in a very similar local environment 
and are also affected by the ring current of F6.   Homonuclear TOCSY and NOESY 
experiments demonstrate clear intra-residue and sequential crosspeaks indicated that the 
chemical shift of I85 has not changed significantly; whereas these experiments suggest 
the new upfield peak is due to protons of the myristoyl group. 
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2D 1H-1H TOCSY (Figure 4.4) and NOESY (Figure 4.5) were adequate for the 
determination of a small number of residue assignments but more importantly for 
assigning myristoyl resonances.  In the homonuclear TOCSY of non-myristoylated 
hisactophilin the δCH3 of I85 peak at -0.803ppm has two strong TOCSY crosspeaks 
which were previously assigned to the γCH2 protons (at -0.09ppm and 0.93ppm).  The 
δCH3 peak also shows a weaker crosspeak with the β proton (at 1.277ppm).  Comparing 
this spectrum with that of the myristoylated protein there are now two sets of upfield 
peaks at slightly different chemical shifts.  A resonance at -0.732ppm shows a similar 
TOCSY pattern to that of δCH3 of I85, with crosspeaks to two putative γCH2 protons at 
0.369ppm and 1.321ppm.  A second resonance -0.824ppm has two overlapping TOCSY 
crosspeaks at -0.118ppm and -0.025ppm, these peaks are significantly shifted from those 
in the non-myristoylated protein. 15N edited 3D TOCSY and NOESY experiments 
confirm that the peak at -0.732ppm is the δCH3 of I85 and the crosspeaks at 0.369ppm 
and 1.321ppm are the γCH2 protons of I85.  Thus, the new upfield resonance at -
0.824ppm and related resonances at -0.118ppm and -0.025ppm likely arise from the 
myristoyl group.  Other aliphatic resonances in the protein core that might resonate in this 
region have been assigned (by 3D heteronuclear TOCSY and NOESY experiments – see 
below), and the resonances are not clearly associated with any other possible side chain.  
We have tentatively assigned the most upfield resonance to the methyl group of the 
myristoyl moiety and the other resonances to CH2 groups; however, these assignments 
should be confirmed by further experiments. 
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Figure 4.4:1H-1H TOCSY of (A) non-myristoylated and (B) myristoylated 
hisactophilin.  Inlays show a magnification of peaks used to assign the δCH3 of 
I85 and the methyl of the myristoyl moiety as discussed in the text. 
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Figure 4.5:1H-1H NOESY of (A) non-myristoylated and (B) myristoylated 
hisactophilin.  Inlays show a magnification of peaks used to assign the δCH3 of 
I85 and the methyl of the myristoyl moiety as discussed in the text. 
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15N-edited 3D TOCSY and NOESY experiments allowed for nearly complete 
sequence specific residue assignments to be deduced and for a further understanding of 
the structural consequences of myristoylation.  From CD and fluorescence experiments, 
which indicated that myristoylated hisactophilin has an overall similar structure as non-
myristoylated hisactophilin (Figure 3.5), one might expect only minor changes in the 
HSQC spectrum and assignments could be made very easily; however, as seen in Figure 
4.6, myristoylation appears to have caused significant chemical shift changes for many 
residues.  A direct comparison of the HSQC spectra of myristoylated and non-
myristoylated hisactophilin suggests that there are only a few large changes in chemical 
shift but numerous minor changes in chemical shift. Hisactophilin amide proton chemical 
shifts are very highly sensitive to pH (Hammond et al., 1998), thus small differences in 
pH may be related to some of the observed differences in the spectra of the myristoylated 
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Figure 4.6: 15N-edited HSQC of (A) non-myristoylated and (B) myristoylated 
hisactophilin. Some of the assigned residues have been labeled to show the significant 
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Another factor complicating the assignment process is the presence of two sets of 
peaks of different intensities for the myristoylated protein.  The lower intensity peaks 
most likely represent a contaminating species and not a second conformation of the 
protein.  If these lower intensity peaks represent a different conformation of the protein 
one would expect their intensities to change with pH due to the likelihood that 
hisactophilin undergoes a pH dependent myristoyl switch; however, the intensity of these 
smaller peaks remain constant over a varying pH range (Figure 4.7).  This suggests that 
these weak peaks must be a contaminating species present after purification.  From the 
previous chapter (section 3.3.1), the purification of myristoylated hisactophilin during 
reverse phase HPLC yields a small peak with a retention time similar to that of 
myristoylated hisactophilin, which was assumed to be hisactophilin acylated with 
something other than myristoyl.  This additional acylated protein may have co-eluted 
with the myristoylated protein.   
 Despite these complications in determining the sequence specific residue 
assignments nearly all of the assignments were completed.  Through the use of 15N-
editied 3D TOCSY to determine spin systems and 15N-editied 3D NOESY experiments 
for through space information 85% of the residues were assigned, the same as for the 
non-myristoylated protein (see Appendix 4 for all assignments made).  Assignments for 
residues located on large loops (such as residues 25-32) or within tight turns (such as 
residues 40-41, 57-58 and 80-81) are often difficult to determine using only 15N labeling 
techniques (Wuthrich, 1989).  Fortunately, since the myristoyl group lies within the 
centre of the beta-barrel, most likely there will be little change in the unassigned residues 














Figure 4.7: 15N-edited HSQC spectra of myristoylated hisactophilin at a variety of different pH values.  HSQC spectra were 
obtained at (A) pH 6.81, (B) pH 7.02, (C) pH 7.24 and (D) pH 7.67.  Note that the weaker intensity peaks do not change intensity 
with pH. 
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A summary of the changes in chemical shift (seen in Figure 4.8) shows that large 
changes in chemical shift are concentrated in several regions of the sequence.  The 
changes in proton chemical shifts (Figure 4.8 A) appear to be distributed throughout the 
entire sequence compared to changes in nitrogen chemical shift (Figure 4.8 B); however, 
as mentioned above, the changes in proton shift may be also affected by pH differences.  
Perturbations in chemical shift are localized in the residues of the beta barrel, most 
prominently in beta-strands 6, 8 and 9.  Likewise, there are large perturbations at the N 
and C termini of the protein.  From these regions of structural rearrangement it is evident 
that the myristoyl moiety sits somewhere within the beta barrel which is further 
confirmed by NOE analysis below. 
Mapping the degree of chemical shift perturbation onto the 3D structure of the 
non-myristoylated protein for each residue (Figure 4.9) allows for a much better 
understanding of the location of the myristoyl group when it is sequestered within the 
protein, as well as regions of structural changes.  The most significant chemical shift 
perturbations are concentrated around I85.  Minor changes in chemical shift also appear 
to be localized to the beta barrel and residues of the hairpin triplet that cap off the beta 
barrel.  This suggests that the myristoyl group lies within the beta barrel which has also 
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Figure 4.8: Histogram of the changes in (A) amide proton chemical shift and 
(B) nitrogen chemical shift caused by myristoylation of hisactophilin.  
Changes in chemical shift are calculated as the absolute value of the change.  



























AtomFigure 4.9: Side (A) and top view (B) for stereo ribbon 
diagrams of non-myristoylated hisactophilin indicating 
the degree of chemical shift change caused by 
myristoylation.  See the legend (right) for colour scheme.  
Inflated spheres represent those amide protons which 
show NOE crosspeaks to the putative methyl of the 
myristoyl group; the magnitude of inflation corresponds 
to the intensity of the NOE.  The N-terminus and point of 
attachment of the myristoyl group is also indicated (M) 
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 In support of this, strong NOEs are found between the methyl of the myristoyl 
group and the amide protons of I85 and V86 and S87.  Similarily, a strong NOE is 
observed between the amide proton of I93 and the myristoyl group.  This indicates that 
the myristoyl group is sequestered deep within the beta barrel and close to I93 which is 
located within the hairpin triplet capping off the beta barrel.  A number of weak NOEs 
are also evident which link the methyl of the myristoyl moiety with the amide protons of 
S84, F74, H75, L76, H94, F113, E114, K45 and T46.  These weak NOEs may only be 
spectral artifacts caused by spin diffusion, overlapping resonances in the myristoyl chain 
or may be due to movement of the myristoyl group within the beta barrel.  Since 
hisactophilin is thought to function with pH dependent myristoyl switch, the myristoyl 
group itself cannot be a static structural element and may have some motion to allow for 
the switch to operate.  In order for the myristoyl group to pack this far within the beta-
barrel there must be some rearrangement of the N-terminus; consistent with this, G2 and 
R4 experience significant perturbations in chemical shift (Figure 4.8 and 4.9).   
 
4.3.2 – Stability of Myristoylated Hisactophilin by Urea Denaturation 
   Preliminary denaturation experiments were performed to obtain a better 
understanding of the stability of the myristoylated form of hisactophilin.  Despite its 
rather unusual core structure, non-myristoylated hisactophilin is a relatively stable protein 
(Lui et al., 2001); adding a myristoyl group to the core may be likely to affect the overall 
stability of the protein.  Although the denaturation studies performed were only 
preliminary, information about the stability of the protein can be extracted from these 
experiments.  A comparison of the midpoints of the denaturation curves (which were 
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found to remain constant over time) allows for a qualitative understanding of protein 
stability.   
From the denaturation curves for myristoylated hisactophilin (Figure 4.10) it is 
evident that a decrease in pH causes a decrease in stability; this is similar to previous 
results obtained for the non-myristoylated form of the protein.  There is only a minor 
change in stability from pH 8.7 to 7.7 and a much more substantial decrease when the pH 
is decreased to 6.7 or 5.7.  Again this trend is similar to that of non-myristoylated protein 
hisactophilin (Lui et al., 2001).  Although the relation of pH and stability are similar for 
both forms of the protein, overall the myristoylated form of the protein is more stable.  
This is similar to what was found through denaturation studies on the myristoylated 
protein frequenin (Muralidhar, 2005).  At pH 7.7 and 8.7, the midpoints of the 
denaturation curves are nearly 1M higher for the myristoylated protein than for the non-
myristoylated protein.  In contrast, at pH 5.7 and 6.7 the midpoints of the curves are only 
~0.3M higher for myristoylated protein.  This trend seems logical since the myristoyl 
switch is thought to occur somewhere around pH 6.7. At high pH values where the 
myristoyl moiety is sequestered deep in the beta barrel may cause an increase in stability 
by allowing for better packing of the protein core.  Whereas, at low pH hisactophilin 
associates with membranes (Hanakam et al., 1996); the myristoyl group has been 
proposed to extend away from the protein and penetrate the hydrophobic interior of the 
plasma membrane (Hanakam et al., 1998).  The relatively smaller stabilization of the 
protein at low pH may favour switching at low pH. 
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Figure 4.10: CD-monitored urea denaturation curves of myristoylated hisactophilin for 
pH 5.7 (■), pH 6.7 (●), pH 7.7 (▲) and pH 8.7 (♦). Data was fit to a two state model 
using the linear extrapolation method according to Liu et al. (2001).  Data fitting at pH 
6.7 may not be reliable due to skewed m values.




















Table 4.1: Comparison of protein stability for myristoylated and non-myristoylated 
hisactophilin determined by urea denaturation 
 
Myristoylated Non-myristoylatedapH Cmid (M)b Cmid (M) 
∆Cmid (M) 
5.7 1.44 ±0.06 1.02 ±0.02 0.42 
6.7 3.43 ±0.04 3.10 ±0.05 0.33 
7.7 5.58 ±0.05 4.31 ±0.01 1.27 
8.7 6.32 ±0.09 5.18 ±0.03 1.14 
a Data was taken from Liu et al. (2001) 
b Data was fit to a two state model using the linear extrapolation 
method according to Liu et al. (2001) 
  97
4.4 – Summary 
 
Overall, the NMR data collected suggests that some structural rearrangement was 
caused by myristoylation.  This structural rearrangement appears to be associated with 
residues of the interior of the beta-barrel, along with residues of the hairpin triplet that 
cap off the beta-barrel.  This information, along with NOE cross-peaks from the protein 
to the myristoyl moiety, suggests that the myristoyl group is sequestered deep in the beta-
barrel at pH 6.81.   
Similar to other myristoylated proteins, hisactophilin demonstrated increased 
stability when myristoylated.  Preliminary denaturation studies showed a significant 
increase in protein stability at a pH above the assumed pH of switching around 6.7; that is 
when the myristoyl group is sequestered within the protein.  Below this pH value 





CHAPTER 5 – SUMMARY AND FUTURE WORK 
 
 
5.1 – Summary 
 
 In general, little has been uncovered on effects that co- and post-translational 
modification have on the structure, stability and folding of a protein;  preliminary NMR 
and denaturation studies of myristoylated hisactophilin were completed to examine these 
effects.  The majority of studies on the molecular basis of myristoyl switches have been 
conducted on characterizing calcium-myristoyl switches, whereas hisactophilin is thought 
to bind reversibly to membranes by means of a pH dependent myristoyl switch. This 
information would be interesting to not only uncover some characteristics of a pH 
dependent myristoyl switch, but more generally to compare the properties of recombinant 
proteins and the naturally modified proteins. 
 This study showed that hisactophilin can be myristoylated using a co-expression 
system in E. coli.  That is the expression of hisactophilin (via the pHW plasmid) along 
with expression of hNMT1 (via the pHV738 plasmid) was successful for the 
myristoylation of hisactophilin.  Through a number of optimization experiments an 86% 
efficiency of myristoylation was achieved, but the total protein yield was not very high 
and may require further optimization.  The addition of a reverse-phase HPLC purification 
step to the existing non-myristoylated hisactophilin purification protocol was successful 
in purifying sufficient amounts of myristoylated protein for preliminary NMR and 
denaturation studies on myristoylated hisactophilin. 
NMR experiments suggested that some structural rearrangement was caused by 
myristoylation.  This structural rearrangement appears limited to the residues of the 
interior of the beta-barrel, along with residues of the hairpin triplet that cap off the beta-
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barrel.  This information, along with protein-myristoyl NOE cross-peaks suggest that the 
myristoyl group is sequestered deep within the beta-barrel at high pH.  Like other 
myristoylated proteins, hisactophilin appears to bind the myristoyl group to a 
hydrophobic region when the myristoyl switch is in the “off” (non-membrane binding) 
position. 
 Also similar to other myristoylated proteins, hisactophilin demonstrated increased 
stability when myristoylated.  Denaturation curves showed a significant increase in 
protein stability at a pH above the assumed pH of switching around 6.7.  Below this pH 
value myristoylated hisactophilin was only slightly more stable.  This difference in 
stability may favour switching but further experimentation is needed to confirm this.  
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5.2 – Future Work 
 
 
5.2.1 – Optimization of Total Protein Yield 
 
 The preparation and purification of myristoylated hisactophilin protocol was 
sufficient for NMR and denaturation experiments performed; however, further 
optimization of the total protein yield needs to be considered.  Preliminary results 
suggested that use of hNMT1 for the co-expression system yielded the highest total 
protein yield but rather low levels of myristoylation.  In addition, the use of sodium 
myristate (as opposed to myristic acid) increased not only the total protein yield, but also 
the level of myristoylation.  Sodium myristate was not used for preparation with hNMT1 
and may result is significantly increased levels of myristoylation as well as high protein 
yields.  Systematic checking of growth parameters such as time of induction can also be 
examined to ensure optimal protein yield. 
 
5.2.2 – Stability of Myristoylated Hisactophilin and Energetics of the Myristoyl Switch 
The denaturation experiments completed were only preliminary and will be 
verified and expanded on.  One key aspect of characterizing stability by denaturation is to 
ensure the system is at equilibrium, as is the case for all thermodynamic measurements 
(Pace et al., 1989).  Liu et al. (2001) have determined that non-myristoylated 
hisactophilin is greater than 90% reversible for urea induced unfolding and at least 80% 
reversible for thermal denaturation (Liu et al., 2001).  To determine reversibility of 
unfolding for myristoylated hisactophilin, the native form of the protein is measured by 
CD or fluorescence.  The protein will then be subjected to a high concentration of 
denaturant and measured again.  The spectrum at this point should resemble that of a 
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fully denatured protein.  Finally, the protein will be exchanged back into a low 
concentration of urea. If this final spectrum resembles the original spectrum, then 
denaturation will be considered to be reversible.   
 In addition to reversibility of denaturation the use of at least a second optical 
probe is needed to verify the results.  Previously, non-myristoylated hisactophilin was 
analyzed using fluorescence and CD.  Further denaturation experiments will allow for not 
only a better understanding of the stabilizing effects of myristoylation, but potentially an 
understanding of the energetics of the myristoyl switch.  Implementation of careful 
control experiments may help to uncover the free energy required for the switch to occur 
– which has not been completed for any myristoylated proteins. The preliminary data 
collected here suggests that at low pH the protein is less stable which may be the 
favourable conditions required for the switch to occur and allow for subsequent binding 
to membranes.  A comparison of the free energy for each state of the switch might allow 
for this. 
 
5.2.3 – Structural Characterization of the Myristoyl Switch 
The structural data obtained by NMR strongly suggest that the myristoyl group is 
sequestered within the beta-barrel of the protein; however, this can be easily confirmed 
through further experimentation.  Assignment of the resonances of myristoyl groups for 
the myristoylated protein recoverin were achieved through a series of multidimensional 
heteronuclear NMR experiments of 13C labeled myristoyl group and 15N labeled protein 
(Tanaka et al., 1995).  These additional experiments will not only allow for verification 
of the location of the myristoyl group but also help in a final structure calculation of 
myristoylated hisactophilin in the myristoyl “off” state. 
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Our results with myristoylated hisactophilin behaves similar to a study of 
recoverin where myristoylation of the protein had caused a significant decrease in 
solubility when the myristoyl switch is in the “off” position (Ames et al., 1997).  This 
would imply that protein solubility is poor under conditions where the myristoyl group is 
solvent exposed – in the case of myristoylated hisactophilin that is at low pH.  To 
overcome these problems, a number of myristic acid analogs have been developed in an 
attempt to increase solubility (Knoll et al., 1995; Ames et al., 1997).  In the case of 
recoverin, solubility difficulties were easily overcome by using a myristoyl analog which 
consisted of an oxygen at position 13 of the fatty acid chain; this analog allowed for 
sufficient solubility and retained protein function (Ames et al., 1997).  Since solubility 
for myristoylated hisactophilin was poor at low pH values incorporation of a myristoyl 
analog will be necessary for a full characterization of the structural consequences caused 
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APPENDIX 1 – VERIFICATION OF MYRISTOYLATION BY MASS 
SPECTROMETRY 
 
Figure A1.1: Mass spectrometry data used to verify myristoylation 
of hisactophilin.  This determined the mass to be 13533 Da 
compared to the expected value of 13532 Da. Data was processed 
using the Micromass software and masses were taken directly from 
these spectra. 
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APPENDIX 2 – PULSE PROGRAMS FOR NMR 
 




;homonuclear Hartman-Hahn transfer using 
DIPSI2 sequence 
; for mixing 
;phase sensitive 
;water suppression using excitation sculpting 
with gradients 
; 
;A.J. Shaka, C.J. Lee & A. Pines, J. Magn. 
Reson. 77, 274 (1988) 
;T.-L. Hwang & A.J. Shaka, J. Magn. Reson., 




















3 d12 pl9:f1 




























































































ph2=0 0 0 0 2 2 2 2 
ph3=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph4=0 0 1 1 
ph5=2 2 3 3 
ph6=0 0 0 0 1 1 1 1 




ph31=0 2 2 0 0 2 2 0 2 0 0 2 2 0 0 2 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl9 : f1 channel - power level for presaturation 
;pl10: f1 channel - power level for TOCSY-
spinlock 
;sp1 : f1 channel - shaped pulse 180 degree 
;p1 : f1 channel - 90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p6 : f1 channel - 90 degree low power pulse 
;p12: f1 channel - 180 degree shaped pulse 
(Squa100.1000) [2 msec] 
;p16: homospoil/gradient pulse 
;d0 : incremented delay (2D) 
;d1 : relaxation delay; 1-5 * T1 
;d9 : TOCSY mixing time 
;d11: delay for disk I/O [30 msec] 
;d12: delay for power switching [20 usec] 
;d13: short delay [4 usec] 
;d16: delay for homospoil/gradient recovery 
;l1: loop for DIPSI cycle: ((p6*115.112) * l1) = 
mixing time 
;in0: 1/(1 * SW) = 2 * DW 
;nd0: 1 
;NS: 8 * n 
;DS: 16 
;td1: number of experiments 
;FnMODE: States-TPPI, TPPI, States or QSEC 
 
;use gradient ratio: gp 1 : gp 2 : gp 3 : gp 4 
; 1 : 3 : 31 : 11 
 












;set pl9 to 120dB when presaturation is not 
required 








;$Id: dipsi2esgpph,v 1.5 2002/06/12 09:04:31 
ber Exp $ 
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A2.2 – 1H-1H NOESY Pulse Program: 
;noesyesgpph 
;avance-version (02/02/07) 
;2D homonuclear correlation via dipolar 
coupling 
;dipolar coupling may be due to noe or chemical 
exchange. 
;phase sensitive 
;water suppression using excitation sculpting 
with gradients 
; 
;T.-L. Hwang & A.J. Shaka, J. Magn. Reson., 















































d1 mc #0 to 2 F1PH(ip1, id0) 
exit 
 
ph1= 0 0 2 2 
ph2= 0 
ph3= 0 0 0 0 2 2 2 2 1 1 1 1 3 3 3 3 
ph4= 0 0 0 0 1 1 1 1 
ph5= 2 2 2 2 3 3 3 3 
ph6= 2 3 
ph7= 0 1 
ph31=0 2 2 0 0 2 2 0 1 3 3 1 1 3 3 1 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;sp1 : f1 channel - shaped pulse 180 degree 
;p1 : f1 channel - 90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p12: f1 channel - 180 degree shaped pulse 
(Squa100.1000) [2 msec] 
;p16: homospoil/gradient pulse 
;d0 : incremented delay (2D) 
;d1 : relaxation delay; 1-5 * T1 
;d8 : mixing time 
;d12: delay for power switching [20 usec] 
;d16: delay for homospoil/gradient recovery 
;in0: 1/(1 * SW) = 2 * DW 
;nd0: 1 
;NS: 8 * n 
;DS: 16 
;td1: number of experiments 
;FnMODE: States-TPPI, TPPI, States or QSEC 
 
;use gradient ratio: gp 1 : gp 2 
; 31 : 11 
 














;$Id: noesyesgpph,v 1.5 2002/06/12 09:05:07 ber 
Exp $  
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A2.3 – 1H-15N HSQC Pulse Program
;invifpf3gpsi 
;avance-version 
;2D H-1/X correlation via double inept transfer 
;   using sensitivity improvement 
;phase sensitive using Echo/Antiecho-TPPI 
gradient selection 
;with decoupling during acquisition 
;using f3 - channel 
;using flip-back pulse 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. 
Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. 
Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. 
Schmidt, O. Schedletzky, 
;   S.J. Glaser, O.W. Sorensen & C. Griesinger, J. 
Biomol. NMR 4, 
;   301-306 (1994) 
;S. Grzesiek & A. Bax, J. Am. Chem. Soc. 115, 
12593-12594 (1993) 
 
define list<gradient> EA=<EA> 
 














define delay DELTA 
define delay DELTA1 
define delay DELTA2 
define delay DELTA3 
define delay DELTA4 
define delay DELTA5 
define delay DELTA6 
define delay DELTA7 
define delay DELTA8 
 
define delay TAU 
define delay TAU1 
define delay TAU2 
define delay TAU3 
define delay TAU4 
define delay TAU5 
;delays for centering pulses 
 
define delay CEN_HN1 
define delay CEN_HN2 
define delay CEN_HN3 
define delay CEN_HC1 
define delay CEN_HC2 
define delay CEN_HC3 
define delay CEN_HC4 
define delay CEN_HP1 
define delay CEN_HP2 
define delay CEN_CN1 
define delay CEN_CN2 
define delay CEN_CN3 
define delay CEN_CN4 
define delay CEN_CP1 




define loopcounter COUNTER 
define loopcounter SCALEF 
define loopcounter FACTOR1 
define loopcounter FACTOR2 
define loopcounter FACTOR3 
 
























  d11 pl16:f3 
2 d1 do:f3 
  6m 
3 d11 
  18m 
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4 (p1 ph1) ph6=0 
  d26 pl3:f3 ph7=0 0 2 2 
  (CEN_HN2 p2 ph2) (p22 ph6):f3 ph31=2 0 0 2 
  d26 setnmr2|0 setnmr0|34|32|33  
  (p1 ph2)  ;pl0 : 120dB 
  4u pl0:f1 ;pl1 : f1 channel - power level for pulse (default) 
  (p11:sp1 ph1:r):f1 ;pl3 : f3 channel - power level for pulse (default) 
  4u ;pl16: f3 channel - power level for CPD/BB 
decoupling   p16:gp1 
  d16 pl1:f1 ;sp1: f1 channel - shaped pulse  90 degree 
  (p21 ph3):f3 ;p1 : f1 channel -  90 degree high power pulse 
  d0  ;p2 : f1 channel - 180 degree high power pulse 
  p2 ph7 ;p11: f1 channel -  90 degree shaped pulse 
  d0 ;p16: homospoil/gradient pulse                         [1 
msec]   p16:gp2*EA 
  d16 ;p21: f3 channel -  90 degree high power pulse 
  (p22 ph4):f3 ;p22: f3 channel - 180 degree high power pulse 
  DELTA ;d0 : incremented delay (2D)                           [3 
usec]   (CEN_HN1 p1 ph1) (p21 ph4):f3 
  d24 ;d1 : relaxation delay; 1-5 * T1 
  (CEN_HN2 p2 ph1) (p22 ph1):f3 ;d11: delay for disk I/O                               [30 
msec]   d24 
  (CEN_HN1 p1 ph2) (p21 ph5):f3 ;d16: delay for homospoil/gradient recovery 
  d26 ;d24: 1/(4J)YH for YH 
  (CEN_HN2 p2 ph1) (p22 ph1):f3 ;     1/(8J)YH for all multiplicities 
  d26 ;d26: 1/(4J(YH)) 
  (p1 ph1) ;cnst4: = J(YH) 
  DELTA1 ;l3: loop for phase sensitive 2D using  E/A 
method : l3 = td1/2   (p2 ph1) 
  4u ;in0: 1/(2 * SW(X)) = DW(X) 
  p16:gp3 ;nd0: 2 
  d16 pl16:f3 ;NS: 1 * n 
  4u setnmr2^0 setnmr0^34^32^33 ;DS: >= 16 
  go=2 ph31 cpd3:f3 ;td1: number of experiments 
  d1 do:f3 wr #0 if #0 zd ;MC2: echo-antiecho 
  3m ip5 igrad EA ;cpd3: decoupling according to sequence defined 
by cpdprg3   3m ip5 
  lo to 3 times 2 ;pcpd3: f3 channel - 90 degree pulse for 
decoupling sequence   d11 id0 
  3m ip3  
  3m ip3 ;use gradient ratio: gp 1 : gp 2 : gp 3 
  3m ip6 ; 50 :   80 : 20.1       for C-13 
  3m ip6 ; 50 :   80 :  8.1       for N-15 
  3m ip31  
  3m ip31 ;for z-only gradients: 
  lo to 4 times l3 ;gpz1: 50% 
exit ;gpz2: 80% 
  ;gpz3: 20.1% for C-13, 8.1% for N-15 
ph1=0   
ph2=1 ;use gradient files:    
ph3=0 2 ;gpnam1: SINE.100 
ph4=0 0 2 2 ;gpnam2: SINE.100 
ph5=1 1 3 3 ;gpnam3: SINE.100 
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;3D sequence with 
;   homonuclear Hartman-Hahn transfer using 
DIPSI2 sequence 
;      for mixing 
;   H-1/X correlation via double inept transfer 
;      using sensitivity improvement 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho-TPPI 
gradient selection (t2) 
;using trim pulses in inept transfer 
;using f3 - channel 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. 
Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. 
Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. 
Schmidt, O. Schedletzky, 
;   S.J. Glaser, O.W. Sorensen & C. Griesinger, J. 
Biomol. NMR 4, 
;   301-306 (1994) 
 






define delay DELTA 
define delay DELTA1 
define delay DELTA2 
define delay DELTA3 
define delay DELTA4 
define delay DELTA5 
define delay DELTA6 
define delay DELTA7 
define delay DELTA8 
 
define delay TAU 
define delay TAU1 
define delay TAU2 
define delay TAU3 
define delay TAU4 
define delay TAU5 
 
;delays for centering pulses 
 
define delay CEN_HN1 
define delay CEN_HN2 
define delay CEN_HN3 
define delay CEN_HC1 
define delay CEN_HC2 
define delay CEN_HC3 
define delay CEN_HC4 
define delay CEN_HP1 
define delay CEN_HP2 
define delay CEN_CN1 
define delay CEN_CN2 
define delay CEN_CN3 
define delay CEN_CN4 
define delay CEN_CP1 




define loopcounter COUNTER 
define loopcounter SCALEF 
define loopcounter FACTOR1 
define loopcounter FACTOR2 
define loopcounter FACTOR3 
 


























# 1 "mc_line 61 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/dipsiif3gpsi3d 
expanding definition part of mc command before 
ze" 
; dimension 3 aq-mode (F2) Echo-Antiecho (F1) 
States-TPPI  F2->F1 
define delay MCWRK 
define delay MCREST 
define loopcounter ST1CNT 
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"ST1CNT = td1 / (2)" 
define loopcounter ST2CNT 
"ST2CNT = td2 / (2)" 
"MCWRK = 0.090909*d11" 




# 1 "mc_line 61 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/dipsiif3gpsi3d 
expanding definition of mc command after ze" 
# 62 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/dipsiif3gpsi3d" 
  d11 pl16:f3 
# 1 "mc_line 63 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/dipsiif3gpsi3d 
expanding start label for mc command" 
2 MCWRK  * 2 do:f3 
LBLSTS2, MCWRK  * 4 
LBLF2, MCWRK  * 4 




3 d12 pl9:f1 
  d1 cw:f1 ph29 
  4u do:f1 
  d12 pl1:f1 
 
  (p1 ph8) 
   DELTA2 pl3:f3 
  (p2 ph9) 
  d0 
  (p22 ph1):f3 
  d0 
  (p1 ph10) 
  d20 pl10:f1 
 
;begin DIPSI2 
7 p6*3.556 ph23 
  p6*4.556 ph25 
  p6*3.222 ph23 
  p6*3.167 ph25 
  p6*0.333 ph23 
  p6*2.722 ph25 
  p6*4.167 ph23 
  p6*2.944 ph25 
  p6*4.111 ph23 
   
  p6*3.556 ph25 
  p6*4.556 ph23 
  p6*3.222 ph25 
  p6*3.167 ph23 
  p6*0.333 ph25 
  p6*2.722 ph23 
  p6*4.167 ph25 
  p6*2.944 ph23 
  p6*4.111 ph25 
 
  p6*3.556 ph25 
  p6*4.556 ph23 
  p6*3.222 ph25 
  p6*3.167 ph23 
  p6*0.333 ph25 
  p6*2.722 ph23 
  p6*4.167 ph25 
  p6*2.944 ph23 
  p6*4.111 ph25 
 
  p6*3.556 ph23 
  p6*4.556 ph25 
  p6*3.222 ph23 
  p6*3.167 ph25 
  p6*0.333 ph23 
  p6*2.722 ph25 
  p6*4.167 ph23 
  p6*2.944 ph25 
  p6*4.111 ph23 
  lo to 7 times l1 
     
 ;end DIPSI2 
 
  d21 pl1:f1 
  (p1 ph11) 
 
  d26 
  (CEN_HN2 p2 ph1) (p22 ph6):f3 
  d26 setnmr2|0 setnmr0|34|32|33 
  p28 ph1 
  d13 
  (p1 ph2)  
  3u 
  p16:gp1 
  d16 
  (p21 ph3):f3 
  d10  
  p2 ph7 
  d10 
  p16:gp2*EA 
  d16 
  (p22 ph4):f3 
  DELTA 
  (CEN_HN1 p1 ph1) (p21 ph4):f3 
  d24 
  (CEN_HN2 p2 ph1) (p22 ph1):f3 
  d24 
  (CEN_HN1 p1 ph2) (p21 ph5):f3 
  d26 
  (CEN_HN2 p2 ph1) (p22 ph1):f3 
  d26 
  (p1 ph1) 
  DELTA1 
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;p28: f1 channel - trim pulse                          [1 
msec] 
  (p2 ph1) 
  d13 
;d0 : incremented delay (F1 in 3D)                     
[3 usec] 
  p16:gp3 
  d16 pl16:f3 
;d1 : relaxation delay; 1-5 * T1   4u setnmr2^0 setnmr0^34^32^33 
;d9 : TOCSY mixing time   go=2 ph31 cpd3:f3 
;d10: incremented delay (F2 in 3D)                     
[3 usec] 
# 1 "mc_line 159 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/dipsiif3gpsi3d 
expanding mc command in line" ;d11: delay for disk I/O                               [30 
msec]   MCWRK  do:f3 wr #0 if #0 zd igrad EA  
MCWRK  ip5*2 ;d12: delay for power switching                        
[20 usec]   lo to LBLSTS2 times 2 
;d13: short delay                                      [4 usec]   MCWRK id10  MCWRK  ip3*2  MCWRK  
ip6*2  MCWRK  ip31*2 ;d16: delay for homospoil/gradient recovery 
;d20: first z-filter delay                           [10 usec]   lo to LBLF2 times ST2CNT 
;d21: second z-filter delay                          [10 
usec] 
  MCWRK rd10  MCWRK  ip8  MCWRK  ip9  
MCWRK  ip29 
;d24: 1/(4J)YH for YH   lo to LBLSTS1 times 2 
;     1/(8J)YH for all multiplicities   MCWRK id0 
;d26: 1/(4J(YH))   lo to LBLF1 times ST1CNT 
;cnst4: = J(YH) # 162 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/dipsiif3gpsi3d" ;l1: loop for DIPSI cycle: ((p6*115.112) * l1) = 
mixing time exit 
;in0: 1/(2 * SW(H)) = DW(H)     
;nd0: 2 ph1=0  
;in10: 1/(2 * SW(X)) = DW(X) ph2=1 
;nd10: 2 ph3=0 2 
;NS: 8 * n ph4=0 0 2 2 
;DS: >= 16 ph5=1 1 3 3 
;td1: number of experiments ph6=0 
;td2: number of experiments in F2 ph7=0 0 2 2 
;FnMODE: States-TPPI (or TPPI) in F1 ph8=0 0 0 0 2 2 2 2 
;FnMODE: echo-antiecho in F2 ph9=1 1 1 1 3 3 3 3 
;cpd3: decoupling according to sequence defined 
by cpdprg3 
ph10=2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
     0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
;pcpd3: f3 channel - 90 degree pulse for 
decoupling sequence 
ph11=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph23=1 
;use gradient ratio:    gp 1 : gp 2 : gp 3 ph25=3 
;                         50 :   80 :  8.1 for N-15 ph29=0 
;                         50 :   80 : 20.1      for C-13 ph31=0 2 2 0 2 0 0 2 2 0 0 2 0 2 2 0 
;for z-only gradients:      2 0 0 2 0 2 2 0 0 2 2 0 2 0 0 2 
;gpz1: 50% ;pl0 : 120dB 
;gpz2: 80% ;pl1 : f1 channel - power level for pulse (default) 
;gpz3: 8.1% for N-15, 20.1% for C-13 ;pl3 : f3 channel - power level for pulse (default) 
 ;pl9 : f1 channel - power level for presaturation 
;use gradient files:    ;pl10: f1 channel - power level for TOCSY-
spinlock ;gpnam1: SINE.100 
;gpnam2: SINE.100 ;pl16: f3 channel - power level for CPD/BB 
decoupling ;gpnam3: SINE.100 
 ;p1 : f1 channel -  90 degree high power pulse 
;set pl9 to 120dB when presaturation is not 
required 
;p2 : f1 channel - 180 degree high power pulse 
;p6 : f1 channel -  90 degree low power pulse 
;   use 70 - 80dB to reduce radiation damping ;p16: homospoil/gradient pulse                         [1 
msec]  
;$Id: dipsiif3gpsi3d,v 1.7.2.1 2001/09/11 
10:14:36 ber Exp$ 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
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;3D sequence with 
;   homonuclear correlation via dipolar coupling 
;   dipolar coupling may be due to noe or 
chemical exchange 
;   H-1/X correlation via double inept transfer 
;      using sensitivity improvement 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho-TPPI 
gradient selection (t2) 
;with decoupling during acquisition 
;using flip-back pulse 
;using f3 - channel 
; 
;O. Zhang, L.E. Kay, J.P. Olivier & J.D. 
Forman-Kay,  
;   J. Biomol. NMR 4, 845 - 858 (1994) 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. 
Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. 
Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. 
Schmidt, O. Schedletzky, 
;   S.J. Glaser, O.W. Sorensen & C. Griesinger, J. 
Biomol. NMR 4, 




define list<gradient> EA=<EA> 
 














define delay DELTA 
define delay DELTA1 
define delay DELTA2 
define delay DELTA3 
define delay DELTA4 
define delay DELTA5 
define delay DELTA6 
define delay DELTA7 
define delay DELTA8 
 
define delay TAU 
define delay TAU1 
define delay TAU2 
define delay TAU3 
define delay TAU4 
define delay TAU5 
 
;delays for centering pulses 
 
define delay CEN_HN1 
define delay CEN_HN2 
define delay CEN_HN3 
define delay CEN_HC1 
define delay CEN_HC2 
define delay CEN_HC3 
define delay CEN_HC4 
define delay CEN_HP1 
define delay CEN_HP2 
define delay CEN_CN1 
define delay CEN_CN2 
define delay CEN_CN3 
define delay CEN_CN4 
define delay CEN_CP1 




define loopcounter COUNTER 
define loopcounter SCALEF 
define loopcounter FACTOR1 
define loopcounter FACTOR2 
define loopcounter FACTOR3 
 



































# 1 "mc_line 67 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesiifpf3gpsi3d 
expanding definition part of mc command before 
ze" 
; dimension 3 aq-mode (F2) Echo-Antiecho (F1) 
States-TPPI  F2->F1 
define delay MCWRK 
define delay MCREST 
define loopcounter ST1CNT 
"ST1CNT = td1 / (2)" 
define loopcounter ST2CNT 
"ST2CNT = td2 / (2)" 
"MCWRK = 0.100000*d11" 




# 1 "mc_line 67 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesiifpf3gpsi3d 
expanding definition of mc command after ze" 
# 68 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesiifpf3gpsi3d" 
  d11 pl16:f3 
# 1 "mc_line 69 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesiifpf3gpsi3d 
expanding start label for mc command" 
2 MCWRK  * 2 do:f3 
LBLSTS2, MCWRK  * 4 
LBLF2, MCWRK  * 3 





  d1  
  (p1 ph8) 
  DELTA2 pl3:f3 
  (p2 ph9) 
  d0 
  (CEN_CN2 p22 ph1):f3 
  d0 
  (p1 ph10) 
  TAU setnmr2|0 setnmr0|34|32|33 
  p16:gp1 
  d16 
  (p1 ph11) 
  d26 
  (CEN_HN2 p2 ph1) (p22 ph6):f3 
  d26 
  (p1 ph2)  
 
  4u pl0:f1 
  (p11:sp1 ph12):f1 
  4u 
  p16:gp2 
  d16 
 
  (p21 ph3):f3 
  d10  
  p2 ph7 
  d10 
  p16:gp3*EA 
  d16 
  (p22 ph4):f3 
  DELTA 
  (CEN_HN1 p1 ph1) (p21 ph4):f3 
  4u 
  p16:gp4 
  DELTA3 
  (CEN_HN2 p2 ph1) (p22 ph1):f3 
  DELTA4 
  p16:gp4 
  d16 
  (CEN_HN1 p1 ph2) (p21 ph5):f3 
  4u 
  p16:gp5 
  DELTA3 
  (CEN_HN2 p2 ph1) (p22 ph1):f3 
  DELTA4 
  p16:gp5 
  d16 
  (p1 ph1) 
  DELTA1 
  (p2 ph1) 
  d13 
  p19:gp6 
  d16 pl16:f3 
  4u setnmr2^0 setnmr0^34^32^33 
  go=2 ph31 cpd3:f3 
# 1 "mc_line 126 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesiifpf3gpsi3d 
expanding mc command in line" 
  MCWRK  do:f3 wr #0 if #0 zd igrad EA  
MCWRK  ip5*2 
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  lo to LBLSTS2 times 2 ;d12: delay for power switching                        
[20 usec]   MCWRK id10  MCWRK  ip3*2  MCWRK  
ip6*2  MCWRK  ip31*2 ;d13: short delay                                      [4 usec] 
  lo to LBLF2 times ST2CNT ;d16: delay for homospoil/gradient recovery 
  MCWRK rd10  MCWRK  ip8  MCWRK  ip9 ;p19: homospoil/gradient pulse                         
[300 usec]   lo to LBLSTS1 times 2 
  MCWRK id0 ;d24: 1/(4J)YH for YH 




;cnst4: = J(YH) 
exit ;in0: 1/(2 * SW(H)) = DW(H) 
   ;nd0: 2 
ph1=0  ;in10: 1/(2 * SW(X)) = DW(X) 
ph2=1 ;nd10: 2 
ph3=0 2 ;NS: 8 * n 
ph4=0 0 2 2 ;DS: >= 16 
ph5=1 1 3 3 ;td1: number of experiments in F1 
ph6=0 ;td2: number of experiments in F2 
ph7=0 0 2 2 ;FnMODE: States-TPPI (or TPPI) in F1 
ph8=0 0 0 0 2 2 2 2 ;FnMODE: echo-antiecho in F2 
ph9=1 1 1 1 3 3 3 3 ;cpd3: decoupling according to sequence defined 
by cpdprg3 ph10=0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
     2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 ;pcpd3: f3 channel - 90 degree pulse for 
decoupling sequence ph11=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph12=2 2 2 2 2 2 2 2 0 0 0 0 0 0 0 0  
ph31=0 2 2 0 2 0 0 2 2 0 0 2 0 2 2 0 ;use gradient ratio: gp 1 : gp 2 : gp 3 :  gp 
4 : gp 5 : gp 6      2 0 0 2 0 2 2 0 0 2 2 0 2 0 0 2 
   ;     30 :  -50 :   80 :    11 
:    5 : 8.1*x ;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default)  
;pl3 : f3 channel - power level for pulse (default) ;   with x = p16/p19 
;pl16: f3 channel - power level for CPD/BB 
decoupling 
 
;for z-only gradients: 
;sp1 : f1 channel - shaped pulse  90 degree ;gpz1: 30% 
;p1 : f1 channel -  90 degree high power pulse ;gpz2: -50% 
;p2 : f1 channel - 180 degree high power pulse ;gpz3: 80% 
;p11: f1 channel -  90 degree shaped pulse ;gpz4: 11% 
;p16: homospoil/gradient pulse                         [1 
msec] 
;gpz5: 5% 
;gpz6: 27% (8.1% *p16(=1 ms)/p19(=300 us)) 
;p21: f3 channel -  90 degree high power pulse  
;p22: f3 channel - 180 degree high power pulse ;use gradient files: 




;d1 : relaxation delay; 1-5 * T1 ;gpnam3: SINE.100 
;d8 : mixing time ;gpnam4: SINE.100 




;d11: delay for disk I/O                               [30 
msec] 
 
;$Id: noesiifpf3gpsi3d,v 1.4 2000/10/06 09:09:32 
ber Exp $ 
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APPENDIX 3 – UREA DENATURATION CURVE SAMPLE PREPARATION 
 
Denaturation samples were prepared according to the following tables for the various pH 
values. 
 
Table A3.1: Urea Denaturation Sample Composition for pH 5.7 
# 












1 30 0 270 0 
2 30 12 258 0.4 
3 30 18 252 0.6 
4 30 24 246 0.8 
5 30 30 240 1 
6 30 36 234 1.2 
7 30 42 228 1.4 
8 30 48 222 1.6 
9 30 54 216 1.8 
10 30 60 210 2 
11 30 66 204 2.2 
12 30 72 198 2.4 
13 30 78 192 2.6 
14 30 84 186 2.8 
15 30 90 180 3 
16 30 102 168 3.4 
17 30 114 156 3.8 
18 30 126 144 4.2 
19 30 138 132 4.6 
20 30 150 120 5 
21 30 162 108 5.4 
22 30 174 96 5.8 
23 30 186 84 6.2 
24 30 198 72 6.6 
25 30 210 60 7 
26 30 222 48 7.4 
27 30 234 36 7.8 
28 30 246 24 8.2 
29 30 258 12 8.6 
30 30 270 0 9 
 
 123
Table A3.2: Urea Denaturation Sample Composition for pH 6.7 
# 











1 30 0 270 0 
2 30 12 258 0.4 
3 30 24 246 0.8 
4 30 36 234 1.2 
5 30 48 222 1.6 
6 30 54 216 1.8 
7 30 60 210 2 
8 30 66 204 2.2 
9 30 72 198 2.4 
10 30 78 192 2.6 
11 30 84 186 2.8 
12 30 90 180 3 
13 30 96 174 3.2 
14 30 102 168 3.4 
15 30 108 162 3.6 
16 30 114 156 3.8 
17 30 120 150 4 
18 30 126 144 4.2 
19 30 138 132 4.6 
20 30 150 120 5 
21 30 162 108 5.4 
22 30 174 96 5.8 
23 30 186 84 6.2 
24 30 198 72 6.6 
25 30 210 60 7 
26 30 222 48 7.4 
27 30 234 36 7.8 
28 30 246 24 8.2 
29 30 258 12 8.6 
30 30 270 0 9 
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Table A3.3: Urea Denaturation Sample Composition for pH 7.7 
# 











1 80 0 720 0 
2 80 32 688 0.4 
3 80 64 656 0.8 
4 80 96 624 1.2 
5 80 128 592 1.6 
6 80 160 560 2 
7 80 192 528 2.4 
8 80 224 496 2.8 
9 80 256 464 3.2 
10 80 288 432 3.6 
11 80 304 416 3.8 
12 80 320 400 4 
13 80 336 384 4.2 
14 80 352 368 4.4 
15 80 368 352 4.6 
16 80 384 336 4.8 
17 80 400 320 5 
18 80 416 304 5.2 
19 80 432 288 5.4 
20 80 448 272 5.6 
21 80 464 256 5.8 
22 80 480 240 6 
23 80 496 224 6.2 
24 80 528 192 6.6 
25 80 560 160 7 
26 80 592 128 7.4 
27 80 624 96 7.8 
28 80 656 64 8.2 
29 80 688 32 8.6 
30 80 720 0 9 
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Table A3.4: Urea Denaturation Sample Composition for pH 8.7 
# 











1 30 0 270 0 
2 30 12 258 0.4 
3 30 24 246 0.8 
4 30 36 234 1.2 
5 30 48 222 1.6 
6 30 60 210 2 
7 30 72 198 2.4 
8 30 84 186 2.8 
9 30 96 174 3.2 
10 30 108 162 3.6 
11 30 120 150 4 
12 30 126 144 4.2 
13 30 132 138 4.4 
14 30 138 132 4.6 
15 30 144 126 4.8 
16 30 150 120 5 
17 30 156 114 5.2 
18 30 162 108 5.4 
19 30 168 102 5.6 
20 30 174 96 5.8 
21 30 180 90 6 
22 30 186 84 6.2 
23 30 192 78 6.4 
24 30 198 72 6.6 
25 30 210 60 7 
26 30 222 48 7.4 
27 30 234 36 7.8 
28 30 246 24 8.2 
29 30 258 12 8.6 
30 30 270 0 9 
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APPENDIX 4 – RESIDUE ASSIGNMENTS FOR MYRISTOYLATED 
HISACTOPHILIN 
 
Residue Assignments made using CARA are listed in Table A4.1 
 
Table A4.1: Residue Assignments for Myristoylated Hisactophilin. 
Residue HN N Hα Hα2 Hβ Hβ2 Hγ Hγ2 Hγ12 Hδ1 Hδ2 Hδ12 
2 G 7.78 111.21 4.48 3.46         
3 N 8.74 120.21 5.64  2.45 2.81       
4 R 9.52 125.89 5.05  1.39 1.21       
5 A 8.42 121.55 4.92  1.29        
6 F 10.08 117.26 5.65  2.64 2.42       
7 K 8.86 125.84 4.42  1.66 1.21   0.19    
8 S 10.00 126.06 4.26          
10 H 7.11 113.63 4.14   3.18       
11 G 7.50 106.22 3.96          
12 H 7.04 117.89 4.90  3.28 2.76       
13 F 9.34 118.90 5.72  3.31 2.93       
14 L 8.46 122.76 4.40  1.84  1.51      
15 S 8.80 117.33 5.09  3.54 3.18       
16 A 8.27 128.14 5.31  1.41        
17 E 8.43 123.52 4.36          
19 E 8.82 124.75 4.50  2.42 2.24   1.86    
20 A 8.17 124.62 4.74  1.45        
21 V 8.21 119.98 4.74  1.92   0.81     
22 K 9.28 127.77 5.01  2.10  1.31      
23 T 7.68 106.08 5.63          
24 H 9.65 120.24 5.11  3.18 2.92       
33 H 7.42 120.54 5.05  3.42 2.84       
34 F 9.60 124.15 5.11  2.92 2.72       
35 H 9.69 123.17 5.05  3.20 3.02       
36 V 8.85 127.71 4.92  2.18  1.11 0.97     
37 E 9.12 126.72 4.54  2.46 2.34   2.04    
38 N 8.59 120.46 5.10  2.75 2.51       
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Residue HN N Hα Hα2 Hβ Hβ2 Hγ Hγ2 Hγ12 Hδ1 Hδ2 Hδ12 
39 H 8.94 125.81 4.62  2.87 2.59       
42 K 7.52 120.29 4.84          
43 V 9.25 112.48 5.73  2.10   1.03     
44 A 8.83 122.64 5.25  1.51        
45 L 10.69 125.84 4.78  1.45        
46 K 8.93 126.69 4.90  2.08    0.47    
47 T 9.41 117.92 4.22          
48 H 9.22 123.13           
50 G 7.79 111.85 4.00 3.28         
51 K 7.71 119.75 4.54  1.47 1.33 0.91      
52 Y 9.04 115.19 5.31   3.12       
53 L 8.94 130.76 4.04  1.92 1.21       
54 S 8.68 121.44 5.45  3.02 2.18       
55 I 8.37 121.50 4.80          
56 G 8.57 108.29 3.22          
59 K 7.77 112.15 3.19          
60 Q 9.18 122.48 4.62  1.92 1.82 2.13      
61 V 8.68 124.20 4.96  1.97    0.91    
62 Y 9.27 127.12 4.94  3.18 2.90       
63 L 8.42 117.89 4.40  2.68 2.32       
64 S 8.37 117.73 4.78  3.82 3.64       
66 H 7.70 114.58 4.94          
67 L 8.64 125.49 4.68  3.02 1.37       
68 H 7.65 132.87 4.12  3.18 2.40       
69 G 8.34 114.42 3.60 3.38         
70 D 8.76 117.19 4.84  2.24 2.44       
71 H 8.88 116.18 4.53   2.60       
72 S 8.60 112.73 5.05   4.14       
73 L 6.16 115.71 5.19  1.51 1.03 1.23      
74 F 9.23 119.02 4.84  2.68 2.50       
75 H 9.46 120.57 4.84  3.18 3.02       
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Residue HN N Hα Hα2 Hβ Hβ2 Hγ Hγ2 Hγ12 Hδ1 Hδ2 Hδ12 
76 L 8.72 126.50 4.78  1.72 1.21       
77 E 8.88 124.95 4.58  2.18    1.88    
78 H 8.45 120.49 5.05  3.16 2.92       
79 K 8.43 122.07 4.52  1.82 1.57       
82 V 7.82 120.36 5.03  2.20 1.94 1.47      
83 S 9.53 115.01 5.53          
84 I 8.63 115.64 5.15   4.38       
85 K 9.42 116.42 5.27  2.00        
86 G 8.57 123.50 4.46  2.96 2.58   0.31 0.95   
87 H 9.27 116.86 4.64 3.66         
89 H 7.81 116.21 3.86  3.02 2.86       
90 H 8.52 113.70 3.92   3.44       
91 H 7.00 116.49 4.72  3.06 2.88       
92 Y 9.19 119.90 5.55  3.16 2.70       
93 I 6.94 118.46 4.36          
94 S 8.72 122.48 5.06  3.32        
95 A 8.60 125.70 5.29  1.41        
96 D 7.84 119.16 4.74  3.24 2.74       
98 H 7.48 117.92 4.44  2.84 2.70       
99 G 8.20 108.23 3.92          
100 H 8.34 121.23 4.78          
101 V 8.85 128.42 5.09          
102 S 8.89 123.83 4.70  3.96 3.80       
103 T 8.40 108.25 5.83          
104 K 8.61 116.66 4.70          
105 E 8.76 120.99 4.00          
106 H 7.23 115.53 4.86          
108 D 8.96 126.73 4.88          
109 H 9.39 117.06 4.34          
110 D 7.81 118.39 4.64  2.84 2.66       
111 T 7.45 108.23 5.17          
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Residue HN N Hα Hα2 Hβ Hβ2 Hγ Hγ2 Hγ12 Hδ1 Hδ2 Hδ12 
112 T 7.47 119.02 4.66  4.04   1.05     
113 F 9.45 123.31 5.11          
114 E 9.42 120.38 4.90  2.34 2.07 1.88 2.15     
115 E 8.95 126.22 4.42      1.98    
116 I 8.81 128.91 4.32  1.66    1.43    
117 I 8.42 128.09 3.80  1.78  0.87      
118 I 6.72 129.57 4.00  1.43  0.67 0.35     
*Unassigned residues are: 9, 18, 19, 25, 26, 27, 28, 29, 30, 31, 32, 38, 40, 41, 49, 57, 58, 
65, 78, 80, 81, 97 and 107 
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